This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid013D |
1. Pulmonary embolism and COVID-19: A paradigm change☆. | *C7321028* C7321028 | ||
2. Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids☆. | *C7306746* C7306746 | ||
3. Pregnancy and perinatal outcome of a woman with COVID-19 infection☆. | *C7306739* C7306739 | ||
4. Solving one of the pieces of the puzzle: COVID-19 and type 2 diabetes☆. | *C7306720* C7306720 | ||
5. Obesity and 2019-nCoV: A risky relationship☆. | *C7261352* C7261352 | ||
6. Características evolución clínica y factores asociados a la mortalidad en UCI de los pacientes críticos infectados por SARS-CoV-2 en España: estudio prospectivo de cohorte y multi-céntrico. | *C7357496* C7357496 | ||
7. Recomendaciones prácticas en la paciente obstétrica con infección por COVID-19. | *C7351396* C7351396 | ||
8. Enfisema subcutáneo masivo en paciente con infección por SARS-COV2. | *C7346768* C7346768 | ||
9. Hallazgos ecocardiográficos en pacientes críticos por COVID-19. | *C7328579* C7328579 | ||
10. Curso clínico de la COVID-19 en pacientes con hipertensión arterial pulmonar. | *C7321018* C7321018 | ||
11. Hitos de la Sección de Cardiología Geriátrica de la Sociedad Española de Cardiología: la r-evolución desde 1995 a 2020. | *C7319918* C7319918 | ||
12. Síndrome de tako-tsubo asociado con COVID-19. | *C7311895* C7311895 | ||
13. Melatonina coronavirus enfermedad cardiovascular y emergencia geriátrica: ¡usemos todo lo que tenemos! Respuesta. | *C7303602* C7303602 | ||
14. Complicaciones arteriales trombóticas en pacientes hospitalizados con COVID-19. | *C7303624* C7303624 | ||
15. Miocarditis fulminante y COVID-19. | *C7301081* C7301081 | ||
16. Embolia pulmonar aguda durante la cuarentena por COVID-19. | *C7296300* C7296300 | ||
17. Trombo en la aurícula derecha tras neumonía por COVID-19. | *C7284256* C7284256 | ||
18. Infarto pulmonar secundario a tromboembolia pulmonar en COVID-19 diagnosticada con angiotomografía computarizada pulmonar con energía dual. | *C7274630* C7274630 | ||
19. Evolución mortal de la enfermedad COVID-19 en un lactante de 5 meses con comorbilidad. | *C7261467* C7261467 | ||
20. Tromboembolia pulmonar en la COVID-19. Cuando nada es lo que parece. | *C7254023* C7254023 | ||
21. Control electrocardiográfico del intervalo QT mediante dispositivo portátil en pacientes ingresados por COVID-19. Propuesta de protocolo. | *C7247495* C7247495 | ||
22. La presencia de cardiopatía agrava el pronóstico de los pacientes con COVID-19. | *C7247473* C7247473 | ||
23. Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia. | *C7346836* C7346836 | ||
24. Cardiac magnetic resonance characterization of COVID-19 myocarditis. | *32694081* 32694081 | ||
25. Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology. | *32694078* 32694078 | ||
26. Neumonía por SARS-CoV-2 (COVID-19): Hallazgo casual en estudio PET/TC con 18F-FDG para el diagnóstico de vasculitis. | *C7351421* C7351421 | ||
27. Infección por SARS-CoV-2: implicaciones para la salud sexual y reproductiva. Una declaración de posición de la Asociación Española de Andrología Medicina Sexual y Reproductiva (ASESA). | *32660697* 32660697 | ||
28. Pneumomédiastin spontané : une complication rare du COVID-19 ? | *32675006* 32675006 | ||
29. A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2. | *32682536* 32682536 | ||
30. COVID-19 and cardiovascular comorbidities: An update. | *C7346786* C7346786 | ||
31. The renin angiotensin aldosterone system and COVID-19. | *C7332203* C7332203 | ||
32. Análisis de las tasas de letalidad de la infección por SARS-CoV-2 en las comunidades autónomas de España. | *C7328631* C7328631 | ||
33. La experiencia de pasar de médicos a enfermos afectados por COVID19. | *C7298488* C7298488 | ||
34. Dolor torácico persistente tras resolución de la enfermedad por coronavirus 2019 (COVID-19). | *32680679* 32680679 | ||
35. Are sex discordant outcomes in COVID-19 related to sex hormones? | *32660890* 32660890 | ||
36. Going viral: A brief history of Chilblain-like skin lesions (“COVID toes”) amidst the COVID-19 pandemic. | *C7245293* C7245293 | ||
37. Involvement of Spike Protein Furin and ACE2 in SARS-CoV-2-Related Cardiovascular Complications. | *C7352091* C7352091 | ||
38. Epidemiological and Clinical Characteristics of 6635 COVID-19 Patients: a Pooled Analysis. | *C7343407* C7343407 | ||
39. Multiple Acute Ischemic Strokes in a COVID-19 Patient: a Case Report. | *C7334131* C7334131 | ||
40. Treatment Approach to Coronavirus Disease (COVID-19) Seen Early After Open Heart Surgery. Case Report. | *C7332244* C7332244 | ||
41. Higher Obesity Trends Among African Americans Are Associated with Increased Mortality in Infected COVID-19 Patients Within the City of Detroit. | *C7324487* C7324487 | ||
42. Extremely Severe Case of COVID-19 Pneumonia Recovered Despite Bad Prognostic Indicators: a Didactic Report. | *C7324074* C7324074 | ||
43. COVID-19 Infection and Haematological Involvement: a Review of Epidemiology Pathophysiology and Prognosis of Full Blood Count Findings. | *C7323879* C7323879 | ||
44. The Association of Cardiovascular Diseases and Diabetes Mellitus with COVID-19 (SARS-CoV-2) and Their Possible Mechanisms. | *C7316523* C7316523 | ||
45. Comorbidity and its Impact on Patients with COVID-19. | *C7314621* C7314621 | ||
46. Conjunctivitis as a Sentinel of SARS-CoV-2 Infection: a Need of Revision for Mild Symptoms. | *C7303432* C7303432 | ||
47. Colitis as a Sole Presentation of SARS-CoV-2 Infection: Case Report. | *C7289076* C7289076 | ||
48. Cardiac Involvement in COVID-19—Assessment with Echocardiography and Cardiac Magnetic Resonance Imaging. | *C7286214* C7286214 | ||
49. Coronavirus: Why Men are More Vulnerable to Covid-19 Than Women? | *C7271824* C7271824 | ||
50. COVID-19 Reinfection: Myth or Truth? | *C7255905* C7255905 | ||
51. Clinical Features of COVID-19 in a Young Man with Massive Cerebral Hemorrhage—Case Report. | *C7245167* C7245167 | ||
52. Pediatric Asthma & Coronavirus (COVID-19)-Clinical Presentation in an Asthmatic Child—Case Report. | *C7235436* C7235436 | ||
53. Acute arterial thrombosis in a breast cancer survivor with coronavirus disease 2019 (COVID-19). | *C7340034* C7340034 | ||
54. Clinical characteristics of emergency surgery patients infected with coronavirus disease 2019 (COVID-19) pneumonia in Wuhan China. | *32675033* 32675033 | ||
55. Pulmonary embolism in hospitalised patients with COVID-19. | *32682004* 32682004 | ||
56. Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen China: A retrospective cohort study. | *32659462* 32659462 | ||
57. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019. | *32659463* 32659463 | ||
58. Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients? | *32663703* 32663703 | ||
59. Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case. | *32688098* 32688098 | ||
60. The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome? | *C7319923* C7319923 | ||
61. Antiphospholipid antibodies and thrombosis in severe COVID-19 pneumonia: A difficult relationship. | *C7319616* C7319616 | ||
62. The hypercoagulable state in COVID-19: Incidence pathophysiology and management. | *C7305763* C7305763 | ||
63. Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases. | *C7303641* C7303641 | ||
64. A comprehensive assessment of the coagulation profile in critically ill COVID-19 patients. | *C7301788* C7301788 | ||
65. Portal vein thrombosis in a patient with COVID-19. | *C7293484* C7293484 | ||
66. Early report on published outcomes in kidney transplant recipients compared to non-transplant patients infected with COVID-19. | *C7357494* C7357494 | ||
67. Bilateral Acute Cardioembolic Limb Ischemia After Coronavirus Disease 2019 Pneumonia in a Lung Transplant Recipient: A Case Report. | *C7324323* C7324323 | ||
68. Use of US to expedite diagnosis of PE in COVID-19 Patient. | *C7269957* C7269957 | ||
69. Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes? | *C7316657* C7316657 | ||
70. Is SARS-CoV-2 (COVID-19) postviral olfactory dysfunction (PVOD) different from other PVOD? | *C7236684* C7236684 | ||
71. Using the internet search data to investigate symptom characteristics of COVID-19: A big data study. | *C7236685* C7236685 | ||
72. Liver profile in COVID-19: a meta-analysis. | *C7241286* C7241286 | ||
73. Cardiovascular comorbidities and complications associated with coronavirus disease 2019. | *C7250768* C7250768 | ||
74. Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina. | *C7335419* C7335419 | ||
75. Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU – A case report. | *C7331532* C7331532 | ||
76. Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination. | *C7319628* C7319628 | ||
77. COVID-19 associated pulmonary aspergillosis (CAPA): An Australian case report. | *C7301813* C7301813 | ||
78. Cardiovascular Implications of COVID-19 Infections. | *32670475* 32670475 | ||
79. COVID-19: A Potential Risk Factor for Acute Pulmonary Embolism. | *32670476* 32670476 | ||
80. Pneumothorax nach COVID-19-Pneumonie. | *32662027* 32662027 | ||
81. Adipositas erhöht Risiko für schweren Verlauf von COVID-19: Corona-Pandemie. | *32662010* 32662010 | ||
82. The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19. | *C7314689* C7314689 | ||
83. Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options. | *32665963* 32665963 | ||
84. 10 Wochen alter Säugling mit Sepsisverdacht und SARS-CoV-2-Nachweis in Liquor und Rachen. | *C7267754* C7267754 | ||
85. COVID-19 in MS and NMOSD: A multicentric online national survey in Chile. | *32683306* 32683306 | ||
86. Multiple sclerosis following SARS-CoV-2 infection. | *32698095* 32698095 | ||
87. Asymptomatic patients and asymptomatic phases of Coronavirus Disease 2019 (COVID-19): a population-based surveillance study. | *C7337770* C7337770 | ||
88. COVID-19 und die Niere. | *C7318905* C7318905 | ||
89. Neurological Involvement in COVID-19 and Potential Mechanisms: A Review. | *32661794* 32661794 | ||
90. Acute necrotizing encephalopathy and myocarditis in a young patient with COVID-19. | *C7286656* C7286656 | ||
91. Neurological manifestations of COVID-19 and other coronaviruses: A systematic review. | *C7261450* C7261450 | ||
92. Guillain-Barré syndrome and SARS-CoV-2. | *C7340740* C7340740 | ||
93. Functional movement disorders in a patient with COVID-19. | *32661885* 32661885 | ||
94. Frequency and outcome of olfactory impairment and sinonasal involvement in hospitalized patients with COVID-19. | *32656713* 32656713 | ||
95. A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients. | *32656711* 32656711 | ||
96. Pre-existing diabetes is worse for SARS-CoV-2 infection; an endothelial perspective. | *C7346795* C7346795 | ||
97. Italian recommendations for the diagnosis of gestational diabetes during COVID-19 pandemic: Position statement AMD-SID diabetes and pregnancy study group. | *32675009* 32675009 | ||
98. Symptoms of COVID-19 Outpatients in the United States. | *C7337847* C7337847 | ||
99. COVID-19-associated multiple organ damage. | *C7336548* C7336548 | ||
100. Invasive Aspergillosis as an Underrecognized Superinfection in COVID-19. | *C7337819* C7337819 | ||
101. Secondary bacterial infections in critical ill patients of COVID-19. | *C7313762* C7313762 | ||
102. Dysgeusia in COVID-19: Possible Mechanisms and Implications. | *32703719* 32703719 | ||
103. Covid-19 in pregnant women and babies: What pediatricians need to know. | *C7293440* C7293440 | ||
104. Can COVID 2019 induce a specific cardiovascular damage or it exacerbates pre-existing cardiovascular diseases? | *C7319650* C7319650 | ||
105. Atypical lymphocyte morphology in SARS-CoV-2 infection. | *C7284261* C7284261 | ||
106. Central Apnea in an Adolescent With COVID-19. | *32674908* 32674908 | ||
107. Coagulopathie associée au COVID-19: les éléments essentiels pour l’anesthésiste-réanimateur. | *C7357462* C7357462 | ||
108. Atteintes neurologiques dans l’infection au SARS-CoV-2 (COVID-19). | *C7351425* C7351425 | ||
109. Prise en charge nutritionnelle des patients de réanimation ayant une infection COVID-19. | *C7351417* C7351417 | ||
110. COVID-19 et Insuffisance rénale aigue en réanimation. | *C7351375* C7351375 | ||
111. Complications cardiaques du Covid-19 en réanimation. | *C7351410* C7351410 | ||
112. COVID-19 and diabetes: What does the clinician need to know? | *32654982* 32654982 | ||
113. Meta-analysis of outcomes of patients with COVID-19 infection with versus without gastrointestinal symptoms. | *C7265105* C7265105 | ||
114. First case diagnosed with both COVID-19 and dengue virus infections in Bangladesh: Possible dengue prevention strategies amid COVID-19 outbreak. | *C7247484* C7247484 | ||
115. Pulmonary Thromboembolism in COVID-19: Venous Thromboembolism or Arterial Thrombosis? | *C7350032* C7350032 | ||
116. Pulmonary Embolism on CTPA in COVID-19 Patients. | *C7336753* C7336753 | ||
117. Pulmonary Vascular Manifestations of COVID-19 Pneumonia. | *C7307217* C7307217 | ||
118. Clarification on Pleural Effusions in COVID-19. | *C7307642* C7307642 | ||
119. COVID-19 Complicated by Acute Pulmonary Embolism. | *C7233431* C7233431 | ||
120. COVID-19-associated encephalopathy: Neurological manifestation of COVID-19. | *C7342008* C7342008 | ||
121. Rhabdomyolysis as a manifestation of a severe case of COVID-19: A case report. | *C7340044* C7340044 | ||
122. Fulminant cerebral edema as a lethal manifestation of COVID-19. | *C7332918* C7332918 | ||
123. COVID-19-associated acute pancreatitis: a rare cause of acute abdomen. | *C7287434* C7287434 | ||
124. Acute myelitis as a neurological complication of Covid-19: A case report and MRI findings. | *C7275163* C7275163 | ||
125. Assisted reproduction and thromboembolic risk in the COVID-19 pandemic. | *32660814* 32660814 | ||
126. The underrecognized prothrombotic vascular disease of COVID‐19. | *C7323147* C7323147 | ||
127. Potential Role of Platelets in COVID‐19: Implications for Thrombosis. | *C7283793* C7283793 | ||
128. Anticoagulation Immortality and Observations of COVID‐19. | *C7283726* C7283726 | ||
129. STudy of Alteplase for Respiratory failure in SARS‐Cov2/COVID‐19: Study Design of the Phase IIa STARS Trial. | *C7280574* C7280574 | ||
130. Pulmonary embolism during the COVID‐19 pandemic: decline in diagnostic procedures and incidence at a University Hospital. | *C7276790* C7276790 | ||
131. Heparin‐induced Thrombocytopenia with Thrombosis in COVID‐19 Adult Respiratory Distress Syndrome. | *C7276726* C7276726 | ||
132. Venous Thromboembolism in Critically Ill Patients with Covid‐19: Results of a Screening Study for Deep Vein Thrombosis. | *C7272794* C7272794 | ||
133. A Proposal for Staging COVID‐19 Coagulopathy. | *C7272892* C7272892 | ||
134. Thrombosis and Thromboembolism Related to COVID‐19 A clarion call for obtaining solid estimates from large‐scale multicenter data. | *C7267431* C7267431 | ||
135. Prognostic value of Cardiac Biomarkers in COVID-19 Infection: A Meta-analysis . | *32702736* 32702736 | ||
136. Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19. | *32702723* 32702723 | ||
137. Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization. | *32658837* 32658837 | ||
138. Letter to the Editor concerning A study on infectivity of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) carriers by Gao et al. | *C7280093* C7280093 | ||
139. Recurrent positive nucleic acid detection in a recovered COVID-19 patient: A case report and literature review. | *C7351047* C7351047 | ||
140. COVID-19 in a patient with active tuberculosis: A rare case-report. | *C7334644* C7334644 | ||
141. Successful recovery from COVID-19 pneumonia after receiving baricitinib tocilizumab and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis. | *C7320265* C7320265 | ||
142. Anosmia: A marker of infection by the new corona virus. | *C7290225* C7290225 | ||
143. Comorbilidad y factores pronósticos al ingreso en una cohorte COVID-19 de un hospital general. | *32680592* 32680592 | ||
144. Does the maternal-fetal transmission of SARS-CoV-2 occur during pregnancy?☆. | *C7351039* C7351039 | ||
145. The COVID-19 Pandemic and Cardiovascular Complications: What Have We Learned So Far? | *C7294283* C7294283 | ||
146. COVID-19 Pneumonia Takotsubo Syndrome and Left Ventricle Thrombi. | *C7290218* C7290218 | ||
147. Acute Multivessel Coronary Occlusion Revealing COVID-19 in a Young Adult. | *C7280128* C7280128 | ||
148. Stress-Induced Cardiomyopathy Precipitated by COVID-19 and Influenza A Coinfection. | *C7280126* C7280126 | ||
149. 4 Cases of Aortic Thrombosis in Patients With COVID-19. | *C7279760* C7279760 | ||
150. Sinus Node Dysfunction in a Young Patient With COVID-19. | *C7279757* C7279757 | ||
151. Severe COVID-19 After Recent Heart Transplantation Complicated by Allograft Dysfunction. | *C7279732* C7279732 | ||
152. SARS-CoV-2 Fulminant Myocarditis. | *C7274592* C7274592 | ||
153. Safety and Efficacy of Amiodarone in a Patient With COVID-19. | *C7259916* C7259916 | ||
154. A Case Series of Stent Thrombosis During the COVID-19 Pandemic. | *C7255188* C7255188 | ||
155. Predisposition or Protection?: COVID-19 in a Patient on LVAD Support With HIV/AIDS. | *C7236747* C7236747 | ||
156. COVID-19 in an Adult With Tricuspid Atresia S/P Fontan Palliation. | *C7236737* C7236737 | ||
157. Thrombosis and Thromboembolism Related to COVID-19: Increase the Level of Awareness Lower the Threshold of Suspicion and Keep Following the Guidelines∗. | *C7236719* C7236719 | ||
158. Complete Heart Block Severe Ventricular Dysfunction and Myocardial Inflammation in a Child With COVID-19 Infection. | *C7237189* C7237189 | ||
159. Difficulties of Managing Submassive and Massive Pulmonary Embolism in the Era of COVID-19. | *C7236704* C7236704 | ||
160. Atrial Arrhythmias in COVID-19 Patients. | *C7253953* C7253953 | ||
161. Transient Renal Tubular Syndromes Associated with Acute COVID-19 Disease. | *C7345486* C7345486 | ||
162. Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis. | *C7314696* C7314696 | ||
163. Epidemiological Clinical and Immunological Features of a Cluster of COVID-19–Contracted Hemodialysis Patients. | *C7282748* C7282748 | ||
164. COVID-19 Infection in Kidney Transplant Recipients: A Single-Center Case Series of 22 Cases From Belgium. | *C7295531* C7295531 | ||
165. Inflammatory olfactory neuropathy in two patients with COVID-19. | *32659210* 32659210 | ||
166. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. | *32659214* 32659214 | ||
167. Coagulation disorder in COVID-19. | *32659213* 32659213 | ||
168. COVID-19-associated pulmonary aspergillosis: adding insult to injury. | *C7333985* C7333985 | ||
169. COVID-19 and fungal superinfection. | *C7333994* C7333994 | ||
170. The role of oral bacteria in COVID-19. | *C7333982* C7333982 | ||
171. Systematic SARS-CoV-2 screening in cerebrospinal fluid during the COVID-19 pandemic. | *C7289579* C7289579 | ||
172. Low rate of bacterial co-infection in patients with COVID-19. | *C7279742* C7279742 | ||
173. Diagnosing COVID-19-associated pulmonary aspergillosis. | *C7211496* C7211496 | ||
174. Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection. | *C7357970* C7357970 | ||
175. COVID-19 in patients with rheumatic disease in Hubei province China: a multicentre retrospective observational study. | *C7333992* C7333992 | ||
176. Pulmonary intravascular coagulopathy in COVID-19 pneumonia – Authors reply. | *C7324112* C7324112 | ||
177. Pulmonary intravascular coagulopathy in COVID-19 pneumonia. | *C7324088* C7324088 | ||
178. Pulmonary intravascular coagulopathy in COVID-19 pneumonia. | *C7324095* C7324095 | ||
179. Pulmonary intravascular coagulopathy in COVID-19 pneumonia. | *C7324089* C7324089 | ||
180. COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study. | *C7302769* C7302769 | ||
181. COVID-19 and systemic lupus erythematosus: a case series. | *C7250558* C7250558 | ||
182. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. | *C7252093* C7252093 | ||
183. Management of multiple myeloma during COVID-19 pandemic. | *C7293439* C7293439 | ||
184. Coronavirus disease 2019 and gender-related mortality in European countries: A meta-analysis. | *C7309755* C7309755 | ||
185. Obesity is Associated with More Critical Illness in COVID-19. | *C7330549* C7330549 | ||
186. Guillain-Barre Syndrome in a Patient With Evidence of Recent SARS-CoV-2 Infection. | *C7284228* C7284228 | ||
187. Prevalence and Mortality of COVID-19 patients with Gastrointestinal Symptoms: A Systematic Review and Meta-analysis. | *C7284248* C7284248 | ||
188. Acute Profound Sensorineural Hearing Loss after COVID-19 Pneumonia. | *C7275185* C7275185 | ||
189. Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis. | *C7275152* C7275152 | ||
190. SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review. | *C7260486* C7260486 | ||
191. Síndrome de guillain-barré tras infección por COVID-19. | *C7346825* C7346825 | ||
192. Riesgo de infección por SARS-CoV-2 y resultados clínicos en pacientes con esclerosis múltiple en la Rioja (España). | *C7346783* C7346783 | ||
193. Infección Y Trombosis Asociada Al Covid-19: Posible Papel Del Grupo Sanguineo Abo. | *C7346773* C7346773 | ||
194. Free-floating right heart thrombus with pulmonary embolism in SARS-CoV-2 patient. | *C7334957* C7334957 | ||
195. Pancitopenia en el curso de infección por SARS-CoV-2. | *C7334956* C7334956 | ||
196. Factores de riesgo y predictores de gravedad en pacientes hospitalizados por COVID-19: análisis de 52 casos. | *32703698* 32703698 | ||
197. The effects of renin-angiotensin system inhibitors (RASI) in Corona Virus Disease (COVID-19) with Hypertension: A retrospective single-center trial. | *C7287454* C7287454 | ||
198. Erupción tipo pitiriasis rosada de Gibert en una paciente asintomática con positividad para COVID-19. | *32654832* 32654832 | ||
199. COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection. | *32663742* 32663742 | ||
200. Does COVID-19 cause permanent damage to olfactory and gustatory function? | *C7346823* C7346823 | ||
201. SARS-CoV-2 infection in a psoriatic arthritis patient treated with IL-17 inhibitor. | *C7328605* C7328605 | ||
202. Into the looking glass: Post-viral syndrome post COVID-19. | *C7320866* C7320866 | ||
203. Will an obesity pandemic replace the coronavirus disease-2019 (COVID-19) pandemic? | *C7316052* C7316052 | ||
204. COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease. | *C7308773* C7308773 | ||
205. Early Mortality Risk Stratification after SARS-CoV-2 Infection. | *C7334967* C7334967 | ||
206. Pneumomediastinum in critically ill adult with COVID-19. | *C7334936* C7334936 | ||
207. Neumomediastino y neumotórax espontáneo en neumonía bilateral por COVID- 19. | *C7316036* C7316036 | ||
208. TROMBO EN TRÁNSITO EN PACIENTE CON NEUMONIA POR COVID-19. | *C7315993* C7315993 | ||
209. Infección grave por coronavirus SARS-CoV-2: experiencia en un hospital de tercer nivel con pacientes afectados por COVID-19 durante la pandemia 2020. | *32654921* 32654921 | ||
210. Preliminary Data on COVID-19 in Patients with Hemoglobinopathies: A Multicentre ICET-A Study. | *32670524* 32670524 | ||
211. Spontaneous and Severe Haematomas in Patients with COVID-19 on Low- Molecular-Weight Heparin for Paroxysmal Atrial Fibrillation. | *32670532* 32670532 | ||
212. Severe Autoimmune Hemolytic Anemia in COVID-19 İnfection Safely Treated with Steroids. | *32670531* 32670531 | ||
213. Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts. | *32670522* 32670522 | ||
214. Impact of SARS CoV-2 in Hemoglobinopathies with Immune Disfunction and Epidemiology. A Protective Mechanism from Beta Chain Hemoglobin Defects? | *32670530* 32670530 | ||
215. commentary: COVID-19 and Obesity: Exploring Biologic Vulnerabilities Structural Disparities and Weight Stigma. | *32673650* 32673650 | ||
216. The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany. | *32673651* 32673651 | ||
145. The COVID-19 Pandemic and Cardiovascular Complications: What Have We Learned So Far? | *C7294283* C7294283 | ||
146. COVID-19 Pneumonia Takotsubo Syndrome and Left Ventricle Thrombi. | *C7290218* C7290218 | ||
147. Acute Multivessel Coronary Occlusion Revealing COVID-19 in a Young Adult. | *C7280128* C7280128 | ||
148. Stress-Induced Cardiomyopathy Precipitated by COVID-19 and Influenza A Coinfection. | *C7280126* C7280126 | ||
149. 4 Cases of Aortic Thrombosis in Patients With COVID-19. | *C7279760* C7279760 | ||
150. Sinus Node Dysfunction in a Young Patient With COVID-19. | *C7279757* C7279757 | ||
151. Severe COVID-19 After Recent Heart Transplantation Complicated by Allograft Dysfunction. | *C7279732* C7279732 | ||
152. SARS-CoV-2 Fulminant Myocarditis. | *C7274592* C7274592 | ||
153. Safety and Efficacy of Amiodarone in a Patient With COVID-19. | *C7259916* C7259916 | ||
154. A Case Series of Stent Thrombosis During the COVID-19 Pandemic. | *C7255188* C7255188 | ||
155. Predisposition or Protection?: COVID-19 in a Patient on LVAD Support With HIV/AIDS. | *C7236747* C7236747 | ||
156. COVID-19 in an Adult With Tricuspid Atresia S/P Fontan Palliation. | *C7236737* C7236737 | ||
157. Thrombosis and Thromboembolism Related to COVID-19: Increase the Level of Awareness Lower the Threshold of Suspicion and Keep Following the Guidelines∗. | *C7236719* C7236719 | ||
158. Complete Heart Block Severe Ventricular Dysfunction and Myocardial Inflammation in a Child With COVID-19 Infection. | *C7237189* C7237189 | ||
159. Difficulties of Managing Submassive and Massive Pulmonary Embolism in the Era of COVID-19. | *C7236704* C7236704 | ||
160. Atrial Arrhythmias in COVID-19 Patients. | *C7253953* C7253953 | ||
161. Transient Renal Tubular Syndromes Associated with Acute COVID-19 Disease. | *C7345486* C7345486 | ||
162. Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis. | *C7314696* C7314696 | ||
163. Epidemiological Clinical and Immunological Features of a Cluster of COVID-19–Contracted Hemodialysis Patients. | *C7282748* C7282748 | ||
164. COVID-19 Infection in Kidney Transplant Recipients: A Single-Center Case Series of 22 Cases From Belgium. | *C7295531* C7295531 | ||
165. Inflammatory olfactory neuropathy in two patients with COVID-19. | *32659210* 32659210 | ||
166. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. | *32659214* 32659214 | ||
167. Coagulation disorder in COVID-19. | *32659213* 32659213 | ||
168. COVID-19-associated pulmonary aspergillosis: adding insult to injury. | *C7333985* C7333985 | ||
169. COVID-19 and fungal superinfection. | *C7333994* C7333994 | ||
170. The role of oral bacteria in COVID-19. | *C7333982* C7333982 | ||
171. Systematic SARS-CoV-2 screening in cerebrospinal fluid during the COVID-19 pandemic. | *C7289579* C7289579 | ||
172. Low rate of bacterial co-infection in patients with COVID-19. | *C7279742* C7279742 | ||
173. Diagnosing COVID-19-associated pulmonary aspergillosis. | *C7211496* C7211496 | ||
174. Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection. | *C7357970* C7357970 | ||
175. COVID-19 in patients with rheumatic disease in Hubei province China: a multicentre retrospective observational study. | *C7333992* C7333992 | ||
176. Pulmonary intravascular coagulopathy in COVID-19 pneumonia – Authors reply. | *C7324112* C7324112 | ||
177. Pulmonary intravascular coagulopathy in COVID-19 pneumonia. | *C7324088* C7324088 | ||
178. Pulmonary intravascular coagulopathy in COVID-19 pneumonia. | *C7324095* C7324095 | ||
179. Pulmonary intravascular coagulopathy in COVID-19 pneumonia. | *C7324089* C7324089 | ||
180. COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study. | *C7302769* C7302769 | ||
181. COVID-19 and systemic lupus erythematosus: a case series. | *C7250558* C7250558 | ||
182. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. | *C7252093* C7252093 | ||
183. Management of multiple myeloma during COVID-19 pandemic. | *C7293439* C7293439 | ||
184. Coronavirus disease 2019 and gender-related mortality in European countries: A meta-analysis. | *C7309755* C7309755 | ||
185. Obesity is Associated with More Critical Illness in COVID-19. | *C7330549* C7330549 | ||
186. Guillain-Barre Syndrome in a Patient With Evidence of Recent SARS-CoV-2 Infection. | *C7284228* C7284228 | ||
187. Prevalence and Mortality of COVID-19 patients with Gastrointestinal Symptoms: A Systematic Review and Meta-analysis. | *C7284248* C7284248 | ||
188. Acute Profound Sensorineural Hearing Loss after COVID-19 Pneumonia. | *C7275185* C7275185 | ||
189. Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis. | *C7275152* C7275152 | ||
190. SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review. | *C7260486* C7260486 | ||
191. Síndrome de guillain-barré tras infección por COVID-19. | *C7346825* C7346825 | ||
192. Riesgo de infección por SARS-CoV-2 y resultados clínicos en pacientes con esclerosis múltiple en la Rioja (España). | *C7346783* C7346783 | ||
193. Infección Y Trombosis Asociada Al Covid-19: Posible Papel Del Grupo Sanguineo Abo. | *C7346773* C7346773 | ||
194. Free-floating right heart thrombus with pulmonary embolism in SARS-CoV-2 patient. | *C7334957* C7334957 | ||
195. Pancitopenia en el curso de infección por SARS-CoV-2. | *C7334956* C7334956 | ||
196. Factores de riesgo y predictores de gravedad en pacientes hospitalizados por COVID-19: análisis de 52 casos. | *32703698* 32703698 | ||
197. The effects of renin-angiotensin system inhibitors (RASI) in Corona Virus Disease (COVID-19) with Hypertension: A retrospective single-center trial. | *C7287454* C7287454 | ||
198. Erupción tipo pitiriasis rosada de Gibert en una paciente asintomática con positividad para COVID-19. | *32654832* 32654832 | ||
199. COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection. | *32663742* 32663742 | ||
200. Does COVID-19 cause permanent damage to olfactory and gustatory function? | *C7346823* C7346823 | ||
201. SARS-CoV-2 infection in a psoriatic arthritis patient treated with IL-17 inhibitor. | *C7328605* C7328605 | ||
202. Into the looking glass: Post-viral syndrome post COVID-19. | *C7320866* C7320866 | ||
203. Will an obesity pandemic replace the coronavirus disease-2019 (COVID-19) pandemic? | *C7316052* C7316052 | ||
204. COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease. | *C7308773* C7308773 | ||
205. Early Mortality Risk Stratification after SARS-CoV-2 Infection. | *C7334967* C7334967 | ||
206. Pneumomediastinum in critically ill adult with COVID-19. | *C7334936* C7334936 | ||
207. Neumomediastino y neumotórax espontáneo en neumonía bilateral por COVID- 19. | *C7316036* C7316036 | ||
208. TROMBO EN TRÁNSITO EN PACIENTE CON NEUMONIA POR COVID-19. | *C7315993* C7315993 | ||
209. Infección grave por coronavirus SARS-CoV-2: experiencia en un hospital de tercer nivel con pacientes afectados por COVID-19 durante la pandemia 2020. | *32654921* 32654921 | ||
210. Preliminary Data on COVID-19 in Patients with Hemoglobinopathies: A Multicentre ICET-A Study. | *32670524* 32670524 | ||
211. Spontaneous and Severe Haematomas in Patients with COVID-19 on Low- Molecular-Weight Heparin for Paroxysmal Atrial Fibrillation. | *32670532* 32670532 | ||
212. Severe Autoimmune Hemolytic Anemia in COVID-19 İnfection Safely Treated with Steroids. | *32670531* 32670531 | ||
213. Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts. | *32670522* 32670522 | ||
214. Impact of SARS CoV-2 in Hemoglobinopathies with Immune Disfunction and Epidemiology. A Protective Mechanism from Beta Chain Hemoglobin Defects? | *32670530* 32670530 | ||
215. commentary: COVID-19 and Obesity: Exploring Biologic Vulnerabilities Structural Disparities and Weight Stigma. | *32673650* 32673650 | ||
216. The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany. | *32673651* 32673651 | ||
PMC7334958 1. COVID-19 and fungal co-infections: We must keep them in mind. | *32651137* 32651137 | ||
PMC7353821 2. Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients. | *32654064* 32654064 | ||
PMC7353824 3. Frontal encephalopathy related to hyperinflammation in COVID-19. | *32654063* 32654063 | ||
PMC7335929 4. The clinical course of SARS-CoV-2 positive neonates. | *32632198* 32632198 | ||
PMC7328547 5. The interplay between COVID 19 and non-communicable diseases. | *32653107* 32653107 | ||
PMC7330334 6. Clinical features of 2019 novel coronavirus infection in Beijing. | *32642164* 32642164 | ||
PMC7330323 7. Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: a multicenter, retrospective, observational study. | *32642086* 32642086 | ||
PMC7330743 8. Hidden risk of nosocomial transmission: a presymptomatic novel coronavirus disease-19 (COVID-19) case with ischemic stroke. | *32642275* 32642275 | ||
PMC7347325 9. Atypical skin manifestations during immune checkpoint blockage in COVID19-infected lung cancer patients. | *32653627* 32653627 | ||
PMC7327193 10. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis. | *32613385* 32613385 | ||
PMC7346854 11. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients. | *32648093* 32648093 | ||
PMC7344037 12. Aortic thrombus in patients with severe COVID-19: review of three cases. | *32648092* 32648092 | ||
PMC7338133 13. Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory? | *32632558* 32632558 | ||
PMC7331913 14. Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19. | *32617807* 32617807 | ||
PMC7330540 15. Successful use of tPA for thrombolysis in COVID related ARDS: a case series. | *32617806* 32617806 | ||
PMC7353827 16. Thrombotic circuit complications during venovenous extracorporeal membrane oxygenation in COVID-19. | *32653986* 32653986 | ||
PMC7332535 17. The timeline and risk factors of clinical progression of COVID-19 in Shenzhen, China. | *32620125* 32620125 | ||
PMC7211616 18. Viral infection-induced thrombosis, novel coronavirus. | *32437948* 32437948 | ||
PMC7266765 19. Reply: Acute Myocarditis With Ventricular Noncompaction in a COVID-19 Patient. | *32616176* 32616176 | ||
PMC7236687 20. Acute Myocarditis With Ventricular Noncompaction in a COVID-19 Patient. | *32616174* 32616174 | ||
PMC7236673 21. COVID-19, End-Stage Heart Failure and Outcome: A Word of Caution in Determining the Causal Link. | *32616173* 32616173 | ||
PMC7275245 22. Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill. | *32501489* 32501489 | ||
PMC7344378 23. Clinical Characteristics of Patients With Coronavirus Disease 2019 (COVID-19) Receiving Emergency Medical Services in King County, Washington. | *32639570* 32639570 | ||
PMC7328572 24. CoVid-19 related dactyitis. | *32622040* 32622040 | ||
PMC7289698 25. Spontaneous Pneumomediastinum in a Patient with Coronavirus Disease 2019 Pneumonia and the Possible Underlying Mechanism. | *32524794* 32524794 | ||
PMC7329282 26. Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective case series. | *32621809* 32621809 | ||
PMC7338012 27. Assessment of patients who tested positive for COVID-19 after recovery. | *32645295* 32645295 | ||
PMC7332281 28. COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study. | *32622380* 32622380 | ||
PMC7332267 29. Neurological associations of COVID-19. | *32622375* 32622375 | ||
PMC7326416 30. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. | *32619408* 32619408 | ||
PMC7340404 31. SARS-CoV-2 infection in conjunctival tissue - Authors' reply. | *32649922* 32649922 | ||
PMC7340386 32. SARS-CoV-2 infection in conjunctival tissue. | *32649921* 32649921 | ||
PMC7326457 33. Immunosuppression in hematological cancer patients with Covid-19 -Uncomplicated infections but delayed viral clearance? | *32652329* 32652329 | ||
PMC7347048 34. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. | *32647324* 32647324 | ||
PMC7341464 35. Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study. | *32641732* 32641732 | ||
PMC7341026 36. Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands. | *32641731* 32641731 | ||
PMC7346808 37. Update on neurological manifestations of COVID-19. | *32652139* 32652139 | ||
PMC7347488 38. The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions. | *32653522* 32653522 | ||
PMC7241409 39. In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. | *32622458* 32622458 | ||
PMC7241320 40. Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. | *32622456* 32622456 | ||
PMC7236707 41. Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide. | *32622449* 32622449 | ||
PMC7237365 42. Purple Fingers and Toes. | *32444162* 32444162 | ||
PMC7205726 43. Eritema multiforme en contexto de infeccion por SARS-Coronavirus-2. | *32475615* 32475615 | ||
PMC7280105 44. Pancreatitis aguda en paciente con infeccion por COVID-19. | *32653210* 32653210 | ||
PMC7316068 45. Coinfeccion por SARS-CoV-2 y virus Epstein-Barr. | *32651071* 32651071 | ||
PMC7315988 46. Relacion entre obesidad, diabetes e ingreso en UCI en pacientes COVID-19. | *32651070* 32651070 | ||
PMC7316050 47. Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors. | *32651067* 32651067 | ||
PMC7174159 48. Rash maculopapuloso como manifestacion inicial de infeccion por SARS-coronavirus-2. | *32402389* 32402389 | ||
PMC7321655 49. Beta-thalassemia may protect against COVID 19. | *32615501* 32615501 | ||
PMC7330550 50. Factors involved in low susceptibility to COVID-19: An adaptation of high altitude inhabitants. | *32634733* 32634733 | ||
PMC7328546 51. Have the symptoms of patients with COVID-19 changed over time during hospitalization? | *32634735* 32634735 | ||
PMC7298456 52. Caracteristicas y resultados de una serie de 59 pacientes con neumonia grave por COVID-19 ingresados en UCI. | *32653237* 32653237 | ||
PMC7298469 53. COVID-19 mortality and health-care resources: Organization. | *32651024* 32651024 | ||
PMC7298463 54. Revision sistematica sobre la utilidad pronostica del dimero-D, coagulacion intravascular diseminada y tratamiento anticoagulante en pacientes graves con COVID-19. | *32646669* 32646669 | ||
PMC7287417 55. Decisiones en UCI basadas en la estrategia Living Systematic Review durante la pandemia de SARS-CoV-2. Resultados de una serie prospectiva de casos. | *32653236* 32653236 | ||
PMC7337580 56. Coronavirus disease 2019 (COVID-19) pneumonia in a hemodialysis patient: A case report. | *32629703* 32629703 | ||
PMC7245178 57. Nephritis signalisiert schweren Verlauf. | *32447709* 32447709 | ||
PMC7245180 58. Schwerer Verlauf bei Adiposen. | *32447701* 32447701 | ||
PMC7313650 59. "Wir vermuten einen Schutzfaktor!" : COVID-19 trifft HIV-Patienten meist nur leicht. | *32583256* 32583256 | ||
PMC7278648 60. Characteristics of COVID-19 disease in multiple sclerosis patients. | *32652473* 32652473 | ||
PMC7318946 61. Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab. | *32622338* 32622338 | ||
PMC7311915 62. A case of possible atypical demyelinating event of the central nervous system following COVID-19. | *32615528* 32615528 | ||
PMC7335234 63. Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy. | *32650121* 32650121 | ||
PMC7233186 64. Association between Angiotensin Blockade and Incidence of Influenza in the United Kingdom. | *32383830* 32383830 | ||
PMC7343863 65. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital. | *32641730* 32641730 | ||
PMC7351556 66. SARS-CoV-2 on the neural battleground. | *32651569* 32651569 | ||
PMC7333223 67. New data emerging on outcomes for patients with COVID-19 and rheumatic diseases. | *32620941* 32620941 | ||
PMC7245262 68. Syndrome of inappropriate antidiuretic hormone as the initial presentation of COVID-19: A novel case report. | *32653253* 32653253 | ||
PMC7245263 69. inverted question markEs la hiporrespuesta inmune de la uremia un factor de proteccion contra la neumonia grave por COVID-19? | *32651085* 32651085 | ||
PMC7287423 70. Papel de la hemodialisis extendida en COVID-19: a proposito de un caso. | *32622483* 32622483 | ||
PMC7341996 71. Two patients with COVID-19 and a fever-induced Brugada-like electrocardiographic pattern. | *32643073* 32643073 | ||
PMC7341471 72. Cardiac function in relation to myocardial injury in hospitalised patients with COVID-19. | *32643071* 32643071 | ||
PMC7329662 73. Neurobiology of coronaviruses: Potential relevance for COVID-19. | *32622086* 32622086 | ||
PMC7323876 74. Cerebral venous thrombosis associated with coronavirus infection: an underestimated entity? | *32601746* 32601746 | ||
PMC7256479 75. Highlights of the issue 6, 2020. | *32472514* 32472514 | ||
PMC7343406 76. Is Guillain-Barre syndrome triggered by SARS-CoV-2? Case report and literature review. | *32643136* 32643136 | ||
PMC7342552 77. Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study. | *32643133* 32643133 | ||
PMC7324486 78. Cerebrovascular disease is associated with the risk of mortality in coronavirus disease 2019. | *32607850* 32607850 | ||
PMC7315937 79. Electroencephalogram (EEG) in COVID-19: A systematic retrospective study. | *32653111* 32653111 | ||
PMC7269896 80. Kan inhalatieanesthesie midazolam vervangen bij ARDS-patienten op de ic? | *32518510* 32518510 | ||
PMC7344348 81. SARS-CoV-2-Infektion und Auge. | *32647981* 32647981 | ||
PMC7289106 82. Thromboinflammation in COVID-19 acute lung injury. | *32653469* 32653469 | ||
PMC7327447 83. Letter to the editor in response to COVID-19 presenting as acute pancreatitis. | *32651079* 32651079 | ||
PMC7167728 84. Spontaneous pneumomediastinum as a complication in human bocavirus infection. | *25336003* 25336003 | ||
PMC7346797 85. Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities. | *32653530* 32653530 | ||
PMC7333201 86. COVID-19 mimicking ST-elevation myocardial infarction. | *32636910* 32636910 | ||
PMC7333504 87. In the eye of the storm: the right ventricle in COVID-19. | *32655856* 32655856 | ||
PMC7351544 88. SARS-CoV-2 and Male Infertility: Possible Multifaceted Pathology. | *32651900* 32651900 | ||
PMC7301784 89. Delayed pulmonary abscess following COVID-19 pneumonia: A case report. | *32623310* 32623310 | ||
PMC7336415 90. Effect of hypertension on outcomes of adult inpatients with COVID-19 in Wuhan, China: a propensity score-matching analysis. | *32631365* 32631365 | ||
PMC7343578 91. Endocrine and metabolic aspects of the COVID-19 pandemic. | *32643004* 32643004 | ||
PMC7303607 92. Fulminant myocarditis and COVID-19. Response. | *32653344* 32653344 | ||
PMC7245226 93. Symptomes gastro-intestinaux initiaux, autres signes de Covid-19. | *32501405* 32501405 | ||
PMC7298481 94. Manejo farmacologico de pacientes con enfermedades hepaticas y pancreaticas que involucran terapias inmunosupresoras. Posicionamiento en el marco de la pandemia de SARS-CoV-2 (COVID-19). | *32620315* 32620315 | ||
PMC7319759 95. COVID-19 and the production of knowledge regarding recommendations during pregnancy: a scoping review. | *32609284* 32609284 | ||
PMC7269521 96. Cerebral Infarction in an Elderly Patient with Coronavirus Disease. | *32520236* 32520236 | ||
PMC7353833 97. Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes. | *32654078* 32654078 | ||
PMC7337803 98. Rhabdomyolysis as the main manifestation of coronavirus disease 2019. | *32584414* 32584414 | ||
PMC7261063 99. The continuum of SARS-CoV-2's neurotropism and the potential for immune-mediated neuronal injury. | *32521503* 32521503 | ||
PMC7275148 100. Prevalence of SARS-CoV-2 infection in general practitioners and nurses in primary care and nursing homes in the Healthcare Area of Leon and associated factors. | *32646731* 32646731 | ||
PMC7275165 101. Trombosis y COVID-19: Atencion Primaria clave en el abordaje interdisciplinar. | *32631646* 32631646 | ||
PMC7274624 102. Posibles factores protectores de la infeccion por SARS-CoV-2 en una paciente vulnerable: a proposito de un caso. | *32631645* 32631645 | ||
PMC7309836 103. Predictive factors of COVID-19 in patients with negative RT-qPCR. | *32651152* 32651152 | ||
PMC7309772 104. Infeccion por SARS-CoV-2 en el embarazo y posibilidad de transmision al neonato: una revision sistematica. | *32646729* 32646729 | ||
PMC7303648 105. COVID-19. La historia se repite y seguimos tropezando con la misma piedra. | *32646730* 32646730 | ||
PMC7287460 106. Erupcion medicamentosa en paciente infectado por SARS-CoV-2. | *32646726* 32646726 | ||
PMC7227488 107. Diabetes and COVID-19. | *32425249* 32425249 | ||
PMC7320673 108. NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection. | *32636031* 32636031 | ||
PMC7319924 109. Demystifying pulmonary vascular complications in severe coronavirus disease-19 pneumonia (COVID-19) in the light of clinico-radiologic-pathologic correlation. | *32620455* 32620455 | ||
PMC7263216 110. Update on acute myocarditis. | *32497572* 32497572 | ||
PMC7346809 111. Understanding The Complex Relationship Between Androgens and SARS-CoV2. | *32653566* 32653566 | ||
PMC7261229 112. Right-Sided Infective Endocarditis. | *32509980* 32509980 | ||
217. ANOSMIA - A REVIEW: IN THE CONTEXT OF COVID 19/OROFACIAL PAIN. | *C7328601* C7328601 | ||
218. The Effects of ARBs ACEis and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents. | *32674818* 32674818 | ||
219. Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19. | *32660924* 32660924 | ||
220. Pneumomediastinum in Mechanically Ventilated Coronavirus Disease 2019 Patients. | *32690234* 32690234 | ||
221. Screening of COVID-19-associated hypercoagulopathy using rotational thromboelastometry. | *32682251* 32682251 | ||
222. Gastrointestinal and Hepatic Involvement in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Review. | *C7287456* C7287456 | ||
223. Pathogenesis of Liver Injury in Coronavirus Disease 2019. | *C7237376* C7237376 | ||
224. Locked-In with COVID-19. | *C7351413* C7351413 | ||
225. Arterial and venous strokes in the setting of COVID-19. | *C7340078* C7340078 | ||
226. Mild encephalopathy with reversible splenium lesion (MERS) in a patient with COVID-19. | *C7340073* C7340073 | ||
227. How SARS-Cov-2 can involve the central nervous system. A systematic analysis of literature of the department of human neurosciences of sapienza university italy. | *C7340069* C7340069 | ||
228. Letter to the editor. Concerning the Article Entitled ‘‘Guillain Barre syndrome associated with COVID-19 infection: A case report”. | *C7334935* C7334935 | ||
229. Clinical characteristics associated with COVID-19 severity in California. | *C7274026* C7274026 | ||
230. SARS-CoV-2 antibody screening in healthcare workers in a tertiary centre in North West England. | *32659709* 32659709 | ||
231. The characteristics and outcomes of 681 severe cases with COVID-19 in China. | *C7340593* C7340593 | ||
232. First-time Diabetic Ketoacidosis in Type 2 Diabetics with COVID-19 Infection: A Novel Case Series. | *C7342034* C7342034 | ||
233. Case Report: Fever Unmasking Brugada-pattern ECG in Patient with Coronavirus Disease 2019 (COVID-19). | *C7293496* C7293496 | ||
234. The Impact of SARS-Cov-2 Virus Infection on the Endocrine System. | *C7337839* C7337839 | ||
235. Epidemiology of the first 100 cases of COVID-19 in Taiwan and its implications on outbreak control. | *C7357534* C7357534 | ||
236. Heart retransplantation following COVID-19 illness in a heart transplant recipient. | *C7338275* C7338275 | ||
237. A case series of novel coronavirus infection in heart transplantation from 2 centers in the pandemic area in the North of Italy. | *C7318961* C7318961 | ||
238. SARS-CoV2 in patients on antiviral HBV and HCV therapy in Spain. | *32673740* 32673740 | ||
239. Influence of inhibitors of the renin–angiotensin system on risk of acute respiratory distress syndrome in Danish hospitalized COVID-19 patients. | *32687274* 32687274 | ||
240. Patterns of HIV and SARS‐CoV‐2 co‐infection in Wuhan China. | *32697865* 32697865 | ||
241. Clinical characteristics of coronavirus disease 2019 in patients aged 80 years and older. | *32690444* 32690444 | ||
242. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. | *C7348129* C7348129 | ||
243. D-dimer: Well beyond diagnosis! | *C7343641* C7343641 | ||
244. Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis. | *C7250752* C7250752 | ||
245. Consecutive false‐negative rRT‐PCR test results for SARS‐CoV‐2 in patients after clinical recovery from COVID‐19. | *C7323315* C7323315 | ||
246. COVID 19 in babies: Knowledge for neonatal care. | *C7340054* C7340054 | ||
247. Hemorrhagic encephalopathy associated with COVID-19. | *32683185* 32683185 | ||
248. Cerebral hemorrhage related to vein thrombosis in Covid-19 patients in different Italian hospitals: View point for clinical and imaging implications. | *32683275* 32683275 | ||
249. Posterior reversible encephalopathy syndrome in patients with COVID-19. | *32679347* 32679347 | ||
250. Relation of Dietary Factors with Infection and Mortality Rates of COVID-19 Across the World. | *C7334895* C7334895 | ||
251. COVID-19 and the Renin Angiotensin System: Implications for the Older Adults. | *C7271637* C7271637 | ||
252. Breast Feeding in Suspected or Confirmed Cases of COVID 19–a New Perspective. | *C7340186* C7340186 | ||
253. Impact of the Coronavirus Infection in Pregnancy: A Preliminary Study of 141 Patients. | *C7340730* C7340730 | ||
254. SARS-CoV-2 Infection and Thrombosis: Phlegmasia Cerulea Dolens Presenting with Venous Gangrene in a Child. | *32673617* 32673617 | ||
255. Intussusception in an infant as a manifestation of COVID-19. | *C7305758* C7305758 | ||
256. Covid-19 and breastfeeding: what’s the risk? | *32661368* 32661368 | ||
257. The landscape of cognitive function in recovered COVID-19 patients. | *C7324344* C7324344 | ||
258. Cerebral Microhemorrhage and Purpuric Rash in COVID-19: The Case for a Secondary Microangiopathy. | *C7348608* C7348608 | ||
259. Bilateral Posterior Cerebral Artery Territory Infarction in a SARS-Cov-2 Infected Patient: discussion about an unusual case. | *C7321046* C7321046 | ||
260. Stroke and COVID19: Not only a large-vessel disease. | *C7303643* C7303643 | ||
261. “COVID-19 and cervical artery dissection- A causative association?”. | *C7293449* C7293449 | ||
262. Hemorrhagic Stroke in Setting of Severe COVID-19 Infection Requiring Extracorporeal Membrane Oxygenation (ECMO). | *C7275181* C7275181 | ||
263. Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection. | *C7274589* C7274589 | ||
264. Cerebral venous thrombosis: A typical presentation of COVID-19 in the young. | *32689590* 32689590 | ||
265. Optimization of resources and modifications in acute ischemic stroke care in response to the global COVID-19 pandemic. | *32689645* 32689645 | ||
266. Hemorrhagic stroke and anticoagulation in COVID-19. | *32689588* 32689588 | ||
267. Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban. | *32689586* 32689586 | ||
268. Thalamic perforating artery stroke on computed tomography perfusion in a patient with coronavirus disease 2019. | *32689589* 32689589 | ||
269. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights. | *32689643* 32689643 | ||
270. Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE). | *C7205703* C7205703 | ||
271. Coagulopathy in COVID-19 infection: a case of acute upper limb ischemia. | *C7332286* C7332286 | ||
272. The need for accurate D‐dimer reporting in COVID‐19: Communication from the ISTH SSC on Fibrinolysis. | *C7307061* C7307061 | ||
273. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. | *32661757* 32661757 | ||
274. SPONTANEOUS MAJOR HEMORRHAGE IN COVID-19 PATIENTS: ANOTHER BRICK IN THE WALL OF SARS COV 2-ASSOCIATED COAGULATION DISORDERS? | *C7311899* C7311899 | ||
275. Skin manifestations of COVID-19 resembling acute limb ischemia. | *C7305762* C7305762 | ||
276. Arterial thromboembolism associated with COVID-19 and elevated D-dimer levels. | *C7297695* C7297695 | ||
277. Acute thrombotic events as initial presentation of patients with COVID-19 infection. | *C7297675* C7297675 | ||
278. Pernio-like eruption associated with COVID-19 in Skin of Color. | *C7354762* C7354762 | ||
279. Relation among right ventricular dysfunction lung damage and mortality in patients with COVID-19. | *C7340028* C7340028 | ||
280. Right Ventricular Longitudinal Strain: a new prognostic tool for COVID-19? | *C7334960* C7334960 | ||
281. Reply to “Relation among right ventricular dysfunction lung damage and mortality in patients with COVID-19” and “Right ventricular longitudinal strain: a new prognostic tool for COVID-19?”. | *C7334948* C7334948 | ||
282. CMR in the era of COVID-19: Evaluation of Myocarditis in the Subacute Phase. | *C7332904* C7332904 | ||
283. Right Ventricular Dilation in Hospitalized Patients with COVID-19 Infection: Authors’ Reply. | *C7330584* C7330584 | ||
284. Right Ventricular Function and Pulmonary Pressures as Independent Predictors of Survival in Patients With COVID-19 Pneumonia. | *32654965* 32654965 | ||
285. Cardiac involvement in recovered COVID-19 patients identified by magnetic resonance imaging. | *C7214335* C7214335 | ||
286. COVID-19 “Fulminant Myocarditis” Successfully Treated With Temporary Mechanical Circulatory Support. | *C7213962* C7213962 | ||
287. Electrical Storm in COVID-19. | *C7259914* C7259914 | ||
288. Right Ventricular Clot in Transit in COVID-19: Implications for the Pulmonary Embolism Response Team. | *C7259913* C7259913 | ||
217. ANOSMIA - A REVIEW: IN THE CONTEXT OF COVID 19/OROFACIAL PAIN. | *C7328601* C7328601 | ||
218. The Effects of ARBs ACEis and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents. | *32674818* 32674818 | ||
219. Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19. | *32660924* 32660924 | ||
220. Pneumomediastinum in Mechanically Ventilated Coronavirus Disease 2019 Patients. | *32690234* 32690234 | ||
221. Screening of COVID-19-associated hypercoagulopathy using rotational thromboelastometry. | *32682251* 32682251 | ||
222. Gastrointestinal and Hepatic Involvement in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Review. | *C7287456* C7287456 | ||
223. Pathogenesis of Liver Injury in Coronavirus Disease 2019. | *C7237376* C7237376 | ||
224. Locked-In with COVID-19. | *C7351413* C7351413 | ||
225. Arterial and venous strokes in the setting of COVID-19. | *C7340078* C7340078 | ||
226. Mild encephalopathy with reversible splenium lesion (MERS) in a patient with COVID-19. | *C7340073* C7340073 | ||
227. How SARS-Cov-2 can involve the central nervous system. A systematic analysis of literature of the department of human neurosciences of sapienza university italy. | *C7340069* C7340069 | ||
228. Letter to the editor. Concerning the Article Entitled ‘‘Guillain Barre syndrome associated with COVID-19 infection: A case report”. | *C7334935* C7334935 | ||
229. Clinical characteristics associated with COVID-19 severity in California. | *C7274026* C7274026 | ||
230. SARS-CoV-2 antibody screening in healthcare workers in a tertiary centre in North West England. | *32659709* 32659709 | ||
231. The characteristics and outcomes of 681 severe cases with COVID-19 in China. | *C7340593* C7340593 | ||
232. First-time Diabetic Ketoacidosis in Type 2 Diabetics with COVID-19 Infection: A Novel Case Series. | *C7342034* C7342034 | ||
233. Case Report: Fever Unmasking Brugada-pattern ECG in Patient with Coronavirus Disease 2019 (COVID-19). | *C7293496* C7293496 | ||
234. The Impact of SARS-Cov-2 Virus Infection on the Endocrine System. | *C7337839* C7337839 | ||
235. Epidemiology of the first 100 cases of COVID-19 in Taiwan and its implications on outbreak control. | *C7357534* C7357534 | ||
236. Heart retransplantation following COVID-19 illness in a heart transplant recipient. | *C7338275* C7338275 | ||
237. A case series of novel coronavirus infection in heart transplantation from 2 centers in the pandemic area in the North of Italy. | *C7318961* C7318961 | ||
238. SARS-CoV2 in patients on antiviral HBV and HCV therapy in Spain. | *32673740* 32673740 | ||
239. Influence of inhibitors of the renin–angiotensin system on risk of acute respiratory distress syndrome in Danish hospitalized COVID-19 patients. | *32687274* 32687274 | ||
240. Patterns of HIV and SARS‐CoV‐2 co‐infection in Wuhan China. | *32697865* 32697865 | ||
241. Clinical characteristics of coronavirus disease 2019 in patients aged 80 years and older. | *32690444* 32690444 | ||
242. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. | *C7348129* C7348129 | ||
243. D-dimer: Well beyond diagnosis! | *C7343641* C7343641 | ||
244. Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis. | *C7250752* C7250752 | ||
245. Consecutive false‐negative rRT‐PCR test results for SARS‐CoV‐2 in patients after clinical recovery from COVID‐19. | *C7323315* C7323315 | ||
246. COVID 19 in babies: Knowledge for neonatal care. | *C7340054* C7340054 | ||
247. Hemorrhagic encephalopathy associated with COVID-19. | *32683185* 32683185 | ||
248. Cerebral hemorrhage related to vein thrombosis in Covid-19 patients in different Italian hospitals: View point for clinical and imaging implications. | *32683275* 32683275 | ||
249. Posterior reversible encephalopathy syndrome in patients with COVID-19. | *32679347* 32679347 | ||
250. Relation of Dietary Factors with Infection and Mortality Rates of COVID-19 Across the World. | *C7334895* C7334895 | ||
251. COVID-19 and the Renin Angiotensin System: Implications for the Older Adults. | *C7271637* C7271637 | ||
252. Breast Feeding in Suspected or Confirmed Cases of COVID 19–a New Perspective. | *C7340186* C7340186 | ||
253. Impact of the Coronavirus Infection in Pregnancy: A Preliminary Study of 141 Patients. | *C7340730* C7340730 | ||
254. SARS-CoV-2 Infection and Thrombosis: Phlegmasia Cerulea Dolens Presenting with Venous Gangrene in a Child. | *32673617* 32673617 | ||
255. Intussusception in an infant as a manifestation of COVID-19. | *C7305758* C7305758 | ||
256. Covid-19 and breastfeeding: what’s the risk? | *32661368* 32661368 | ||
257. The landscape of cognitive function in recovered COVID-19 patients. | *C7324344* C7324344 | ||
258. Cerebral Microhemorrhage and Purpuric Rash in COVID-19: The Case for a Secondary Microangiopathy. | *C7348608* C7348608 | ||
259. Bilateral Posterior Cerebral Artery Territory Infarction in a SARS-Cov-2 Infected Patient: discussion about an unusual case. | *C7321046* C7321046 | ||
260. Stroke and COVID19: Not only a large-vessel disease. | *C7303643* C7303643 | ||
261. “COVID-19 and cervical artery dissection- A causative association?”. | *C7293449* C7293449 | ||
262. Hemorrhagic Stroke in Setting of Severe COVID-19 Infection Requiring Extracorporeal Membrane Oxygenation (ECMO). | *C7275181* C7275181 | ||
263. Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection. | *C7274589* C7274589 | ||
264. Cerebral venous thrombosis: A typical presentation of COVID-19 in the young. | *32689590* 32689590 | ||
265. Optimization of resources and modifications in acute ischemic stroke care in response to the global COVID-19 pandemic. | *32689645* 32689645 | ||
266. Hemorrhagic stroke and anticoagulation in COVID-19. | *32689588* 32689588 | ||
267. Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban. | *32689586* 32689586 | ||
268. Thalamic perforating artery stroke on computed tomography perfusion in a patient with coronavirus disease 2019. | *32689589* 32689589 | ||
269. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights. | *32689643* 32689643 | ||
270. Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE). | *C7205703* C7205703 | ||
271. Coagulopathy in COVID-19 infection: a case of acute upper limb ischemia. | *C7332286* C7332286 | ||
272. The need for accurate D‐dimer reporting in COVID‐19: Communication from the ISTH SSC on Fibrinolysis. | *C7307061* C7307061 | ||
273. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. | *32661757* 32661757 | ||
274. SPONTANEOUS MAJOR HEMORRHAGE IN COVID-19 PATIENTS: ANOTHER BRICK IN THE WALL OF SARS COV 2-ASSOCIATED COAGULATION DISORDERS? | *C7311899* C7311899 | ||
275. Skin manifestations of COVID-19 resembling acute limb ischemia. | *C7305762* C7305762 | ||
276. Arterial thromboembolism associated with COVID-19 and elevated D-dimer levels. | *C7297695* C7297695 | ||
277. Acute thrombotic events as initial presentation of patients with COVID-19 infection. | *C7297675* C7297675 | ||
278. Pernio-like eruption associated with COVID-19 in Skin of Color. | *C7354762* C7354762 | ||
279. Relation among right ventricular dysfunction lung damage and mortality in patients with COVID-19. | *C7340028* C7340028 | ||
280. Right Ventricular Longitudinal Strain: a new prognostic tool for COVID-19? | *C7334960* C7334960 | ||
281. Reply to “Relation among right ventricular dysfunction lung damage and mortality in patients with COVID-19” and “Right ventricular longitudinal strain: a new prognostic tool for COVID-19?”. | *C7334948* C7334948 | ||
282. CMR in the era of COVID-19: Evaluation of Myocarditis in the Subacute Phase. | *C7332904* C7332904 | ||
283. Right Ventricular Dilation in Hospitalized Patients with COVID-19 Infection: Authors’ Reply. | *C7330584* C7330584 | ||
284. Right Ventricular Function and Pulmonary Pressures as Independent Predictors of Survival in Patients With COVID-19 Pneumonia. | *32654965* 32654965 | ||
285. Cardiac involvement in recovered COVID-19 patients identified by magnetic resonance imaging. | *C7214335* C7214335 | ||
286. COVID-19 “Fulminant Myocarditis” Successfully Treated With Temporary Mechanical Circulatory Support. | *C7213962* C7213962 | ||
287. Electrical Storm in COVID-19. | *C7259914* C7259914 | ||
288. Right Ventricular Clot in Transit in COVID-19: Implications for the Pulmonary Embolism Response Team. | *C7259913* C7259913 | ||
289. The saga continues: is COVID-19 a cardiopulmonary disease? | *C7314074* C7314074 | ||
290. Ventricular tachycardia storm management in a COVID-19 patient: a case report. | *C7337657* C7337657 | ||
291. Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report. | *C7337643* C7337643 | ||
292. COVID19: a case report of thrombus in transit. | *C7337692* C7337692 | ||
293. Transient Type 1 Brugada Pattern without Ongoing Fever during COVID-19 Pneumonia. | *32665941* 32665941 | ||
294. Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment. | *32665940* 32665940 | ||
295. Unusually Rapid Development of Pulmonary Hypertension and Right Ventricular Failure after COVID-19 Pneumonia. | *32665939* 32665939 | ||
296. Cutaneous Complications Secondary to Haemostasis Abnormalities in COVID-19 Infection. | *32665938* 32665938 | ||
297. COVID-19 in a Patient with Chronic Lymphocytic Leukaemia with Pseudohypoxemia. | *32665936* 32665936 | ||
298. Erythematous Papular Rash: A Dermatological Feature of COVID-19. | *32665937* 32665937 | ||
299. Immune Thrombocytopenic Purpura in Patients with COVID-19. | *32665935* 32665935 | ||
300. Can Lung Ultrasound be Used to Screen for Pulmonary Embolism in Patients with SARS-CoV-2 Pneumonia? | *32665934* 32665934 | ||
301. Multisystemic Infarctions in COVID-19: Focus on the Spleen. | *32665933* 32665933 | ||
302. COVID-19 Chronic Obstructive Pulmonary Disease and Pneumothorax: A Frightening Triad. | *32665932* 32665932 | ||
303. Vertical transmission of SARS-CoV-2 infection and preterm birth. | *32661809* 32661809 | ||
304. Late miscarriage as a presenting manifestation of COVID-19. | *32690331* 32690331 | ||
305. Ethical considerations relevant to infections in pregnancy: Application to Sars-Covid-19. | *32682631* 32682631 | ||
306. Proteinuria in Covid-19 pregnant women: Preeclampsia or severe infection? | *32654789* 32654789 | ||
307. Anosmia: a COVID-19 symptom that must be investigated by rhinoplasty surgeons. | *C7355516* C7355516 | ||
308. Acute Aortic Thrombosis Revealing a COVID-19 Infection. | *C7340082* C7340082 | ||
309. Re: Lan Zhu Nianqiao Gong Bin Liu et al. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan China. Eur Urol 2020;77:748–54. | *32660746* 32660746 | ||
310. Reply to Amit Bansal and Anant Kumar’s Letter to the Editor re: Lan Zhu Nianqiao Gong Bin Liu et al. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan China. Eur Urol 2020;77:748–54. | *32654803* 32654803 | ||
311. Comment on: “Care for critically ill patients with COVID-19: don’t forget the eyes”. | *32661338* 32661338 | ||
312. Foot manifestations in a patient with COVID-19 and Epstein-Barr virus: A case study. | *C7313890* C7313890 | ||
313. Systematic Review and Meta-Analysis of Sex-Specific COVID-19 Clinical Outcomes. | *32671082* 32671082 | ||
314. A Low Viral Dose in COVID-19 Patient: A Case Report. | *32671013* 32671013 | ||
315. COVID-19 and coronaviral hepatitis: evidence of collateral damage. | *C7291768* C7291768 | ||
316. Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection. | *C7291769* C7291769 | ||
317. A suspected case of COVID-19 turned into a confirmed case: a case report from Iran. | *C7265682* C7265682 | ||
318. Revisión de nuevas evidencias acerca de la posible transmisión vertical de la COVID-19. | *C7305917* C7305917 | ||
319. Actualización en COVID-19 y enfermedad hepática. | *C7332955* C7332955 | ||
320. Dysentery as a rare GI symptom found in COVID-19 patients. | *C7332941* C7332941 | ||
321. Afectación del aparato digestivo en la COVID-19. Una revisión sobre el tema. | *C7303613* C7303613 | ||
322. Hepatology in the COVID Era: Another C Virus again Challenging the Liver. | *C7273910* C7273910 | ||
323. Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process. | *C7211082* C7211082 | ||
324. Schwangerschaft Geburt und Wochenbett mit SARS-CoV-2 und COVID-19 . | *C7357434* C7357434 | ||
325. The need for GIScience in mapping COVID-19. | *C7328589* C7328589 | ||
326. Increased mortality among hypertensive COVID-19 patients: Pay a closer look on diuretics in mechanically ventilated patients. | *32693957* 32693957 | ||
327. Post-Intensive care syndrome and COVID-19: crisis after a crisis? | *32690219* 32690219 | ||
328. Coronavirus disease 2019 (Covid-19) presenting as purulent fulminant myopericarditis and cardiac tamponade: A case report and literature review. | *32693958* 32693958 | ||
329. Heart block in patients with coronavirus disease 2019: A case series of 3 patients infected with SARS-CoV-2. | *C7311354* C7311354 | ||
330. Temperature monitoring with an implantable loop recorder in a patient with presumed COVID-19. | *C7273165* C7273165 | ||
331. MEDICATION UNMASKED BRUGADA SYNDROME AND CARDIAC ARREST IN A COVID-19 PATIENT. | *C7245294* C7245294 | ||
332. Coronavirus Disease 2019 (COVID‐19) in autoimmune hepatitis: a lesson from immunosuppressed patients. | *C7300554* C7300554 | ||
333. Acute abdomen -like-presentation associated with SARS-CoV-2 infection. | *C7333611* C7333611 | ||
334. Acute life-threatening cardiac tamponade in a mechanically ventilated patient with COVID-19 pneumonia. | *C7331566* C7331566 | ||
335. COVID-19 and Plasmodium vivax malaria co-infection. | *C7305490* C7305490 | ||
336. COVID-19 in Adult Patients with Hematological Disease: Analysis of Clinical Characteristics and Outcomes. | *C7339791* C7339791 | ||
337. COVID19 Infection in Health Care Professionals: Risks Work-Safety and Psychological Issues. | *C7320845* C7320845 | ||
338. COVID-19 and Acute Pancreatitis: What Do Surgeons Need to Know? | *C7272589* C7272589 | ||
339. Potential of age distribution profiles for the prediction of COVID-19 infection origin in a patient group. | *C7271873* C7271873 | ||
340. COVID-19 Presenting as Takotsubo Cardiomyopathy Complicated with Atrial Fibrillation. | *C7348613* C7348613 | ||
341. An updated meta‐analysis on the relationship between D‐dimer levels and severity of coronavirus disease 2019. | *C7323447* C7323447 | ||
342. Thrombocytopenia in pregnant patients with mild COVID-19. | *32673964* 32673964 | ||
343. Early bacterial co-infection in ARDS related to COVID-19. | *32661615* 32661615 | ||
344. Evaluating the evidence for direct central nervous system invasion in patients infected with the nCOVID-19 virus. | *C7351657* C7351657 | ||
345. Encephalitis associated with the SARS-CoV-2 virus: A case report. | *C7347479* C7347479 | ||
346. Targeting of renin-angiotensin system in COVID-19 patients affected by stroke: Emerging concerns about detrimental vs. benefit effect. | *C7347486* C7347486 | ||
347. Posterior reversible encephalopathy syndrome (PRES): Another imaging manifestation of COVID-19. | *C7308006* C7308006 | ||
348. Renin-Angiotensin System Blockade in COVID-19: Good Bad or Indifferent?∗. | *32674791* 32674791 | ||
349. Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis. | *C7323310* C7323310 | ||
350. Man with severe COVID pneumonia. | *C7323045* C7323045 | ||
351. Unexpected finding of myocardial depression in 2 healthy young patients with COVID‐19 pneumonia: possible support for COVID‐19‐related myocarditis. | *C7323425* C7323425 | ||
352. Man with productive cough. | *C7323173* C7323173 | ||
353. Patient factors associated with SARS‐CoV‐2 in an admitted emergency department population. | *C7280703* C7280703 | ||
354. An elderly woman with respiratory distress. | *C7262327* C7262327 | ||
355. Man with fever cough and atypical chest pain. | *C7262122* C7262122 | ||
356. Tomographic Findings and Thrombogenic Effects of COVID-19. | *C7357503* C7357503 | ||
357. Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study. | *32674821* 32674821 | ||
358. COVID-19: review of case reports. | *32656688* 32656688 | ||
359. Syncope Brugada syndrome and COVID‐19 lung disease. | *C7323040* C7323040 | ||
289. The saga continues: is COVID-19 a cardiopulmonary disease? | *C7314074* C7314074 | ||
290. Ventricular tachycardia storm management in a COVID-19 patient: a case report. | *C7337657* C7337657 | ||
291. Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report. | *C7337643* C7337643 | ||
292. COVID19: a case report of thrombus in transit. | *C7337692* C7337692 | ||
293. Transient Type 1 Brugada Pattern without Ongoing Fever during COVID-19 Pneumonia. | *32665941* 32665941 | ||
294. Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment. | *32665940* 32665940 | ||
295. Unusually Rapid Development of Pulmonary Hypertension and Right Ventricular Failure after COVID-19 Pneumonia. | *32665939* 32665939 | ||
296. Cutaneous Complications Secondary to Haemostasis Abnormalities in COVID-19 Infection. | *32665938* 32665938 | ||
297. COVID-19 in a Patient with Chronic Lymphocytic Leukaemia with Pseudohypoxemia. | *32665936* 32665936 | ||
298. Erythematous Papular Rash: A Dermatological Feature of COVID-19. | *32665937* 32665937 | ||
299. Immune Thrombocytopenic Purpura in Patients with COVID-19. | *32665935* 32665935 | ||
300. Can Lung Ultrasound be Used to Screen for Pulmonary Embolism in Patients with SARS-CoV-2 Pneumonia? | *32665934* 32665934 | ||
301. Multisystemic Infarctions in COVID-19: Focus on the Spleen. | *32665933* 32665933 | ||
302. COVID-19 Chronic Obstructive Pulmonary Disease and Pneumothorax: A Frightening Triad. | *32665932* 32665932 | ||
303. Vertical transmission of SARS-CoV-2 infection and preterm birth. | *32661809* 32661809 | ||
304. Late miscarriage as a presenting manifestation of COVID-19. | *32690331* 32690331 | ||
305. Ethical considerations relevant to infections in pregnancy: Application to Sars-Covid-19. | *32682631* 32682631 | ||
306. Proteinuria in Covid-19 pregnant women: Preeclampsia or severe infection? | *32654789* 32654789 | ||
307. Anosmia: a COVID-19 symptom that must be investigated by rhinoplasty surgeons. | *C7355516* C7355516 | ||
308. Acute Aortic Thrombosis Revealing a COVID-19 Infection. | *C7340082* C7340082 | ||
309. Re: Lan Zhu Nianqiao Gong Bin Liu et al. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan China. Eur Urol 2020;77:748–54. | *32660746* 32660746 | ||
310. Reply to Amit Bansal and Anant Kumar’s Letter to the Editor re: Lan Zhu Nianqiao Gong Bin Liu et al. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan China. Eur Urol 2020;77:748–54. | *32654803* 32654803 | ||
311. Comment on: “Care for critically ill patients with COVID-19: don’t forget the eyes”. | *32661338* 32661338 | ||
312. Foot manifestations in a patient with COVID-19 and Epstein-Barr virus: A case study. | *C7313890* C7313890 | ||
313. Systematic Review and Meta-Analysis of Sex-Specific COVID-19 Clinical Outcomes. | *32671082* 32671082 | ||
314. A Low Viral Dose in COVID-19 Patient: A Case Report. | *32671013* 32671013 | ||
315. COVID-19 and coronaviral hepatitis: evidence of collateral damage. | *C7291768* C7291768 | ||
316. Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection. | *C7291769* C7291769 | ||
317. A suspected case of COVID-19 turned into a confirmed case: a case report from Iran. | *C7265682* C7265682 | ||
318. Revisión de nuevas evidencias acerca de la posible transmisión vertical de la COVID-19. | *C7305917* C7305917 | ||
319. Actualización en COVID-19 y enfermedad hepática. | *C7332955* C7332955 | ||
320. Dysentery as a rare GI symptom found in COVID-19 patients. | *C7332941* C7332941 | ||
321. Afectación del aparato digestivo en la COVID-19. Una revisión sobre el tema. | *C7303613* C7303613 | ||
322. Hepatology in the COVID Era: Another C Virus again Challenging the Liver. | *C7273910* C7273910 | ||
323. Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process. | *C7211082* C7211082 | ||
324. Schwangerschaft Geburt und Wochenbett mit SARS-CoV-2 und COVID-19 . | *C7357434* C7357434 | ||
325. The need for GIScience in mapping COVID-19. | *C7328589* C7328589 | ||
326. Increased mortality among hypertensive COVID-19 patients: Pay a closer look on diuretics in mechanically ventilated patients. | *32693957* 32693957 | ||
327. Post-Intensive care syndrome and COVID-19: crisis after a crisis? | *32690219* 32690219 | ||
328. Coronavirus disease 2019 (Covid-19) presenting as purulent fulminant myopericarditis and cardiac tamponade: A case report and literature review. | *32693958* 32693958 | ||
329. Heart block in patients with coronavirus disease 2019: A case series of 3 patients infected with SARS-CoV-2. | *C7311354* C7311354 | ||
330. Temperature monitoring with an implantable loop recorder in a patient with presumed COVID-19. | *C7273165* C7273165 | ||
331. MEDICATION UNMASKED BRUGADA SYNDROME AND CARDIAC ARREST IN A COVID-19 PATIENT. | *C7245294* C7245294 | ||
332. Coronavirus Disease 2019 (COVID‐19) in autoimmune hepatitis: a lesson from immunosuppressed patients. | *C7300554* C7300554 | ||
333. Acute abdomen -like-presentation associated with SARS-CoV-2 infection. | *C7333611* C7333611 | ||
334. Acute life-threatening cardiac tamponade in a mechanically ventilated patient with COVID-19 pneumonia. | *C7331566* C7331566 | ||
335. COVID-19 and Plasmodium vivax malaria co-infection. | *C7305490* C7305490 | ||
336. COVID-19 in Adult Patients with Hematological Disease: Analysis of Clinical Characteristics and Outcomes. | *C7339791* C7339791 | ||
337. COVID19 Infection in Health Care Professionals: Risks Work-Safety and Psychological Issues. | *C7320845* C7320845 | ||
338. COVID-19 and Acute Pancreatitis: What Do Surgeons Need to Know? | *C7272589* C7272589 | ||
339. Potential of age distribution profiles for the prediction of COVID-19 infection origin in a patient group. | *C7271873* C7271873 | ||
340. COVID-19 Presenting as Takotsubo Cardiomyopathy Complicated with Atrial Fibrillation. | *C7348613* C7348613 | ||
341. An updated meta‐analysis on the relationship between D‐dimer levels and severity of coronavirus disease 2019. | *C7323447* C7323447 | ||
342. Thrombocytopenia in pregnant patients with mild COVID-19. | *32673964* 32673964 | ||
343. Early bacterial co-infection in ARDS related to COVID-19. | *32661615* 32661615 | ||
344. Evaluating the evidence for direct central nervous system invasion in patients infected with the nCOVID-19 virus. | *C7351657* C7351657 | ||
345. Encephalitis associated with the SARS-CoV-2 virus: A case report. | *C7347479* C7347479 | ||
346. Targeting of renin-angiotensin system in COVID-19 patients affected by stroke: Emerging concerns about detrimental vs. benefit effect. | *C7347486* C7347486 | ||
347. Posterior reversible encephalopathy syndrome (PRES): Another imaging manifestation of COVID-19. | *C7308006* C7308006 | ||
348. Renin-Angiotensin System Blockade in COVID-19: Good Bad or Indifferent?∗. | *32674791* 32674791 | ||
349. Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis. | *C7323310* C7323310 | ||
350. Man with severe COVID pneumonia. | *C7323045* C7323045 | ||
351. Unexpected finding of myocardial depression in 2 healthy young patients with COVID‐19 pneumonia: possible support for COVID‐19‐related myocarditis. | *C7323425* C7323425 | ||
352. Man with productive cough. | *C7323173* C7323173 | ||
353. Patient factors associated with SARS‐CoV‐2 in an admitted emergency department population. | *C7280703* C7280703 | ||
354. An elderly woman with respiratory distress. | *C7262327* C7262327 | ||
355. Man with fever cough and atypical chest pain. | *C7262122* C7262122 | ||
356. Tomographic Findings and Thrombogenic Effects of COVID-19. | *C7357503* C7357503 | ||
357. Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study. | *32674821* 32674821 | ||
358. COVID-19: review of case reports. | *32656688* 32656688 | ||
359. Syncope Brugada syndrome and COVID‐19 lung disease. | *C7323040* C7323040 | ||
PMC7328443 113. Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans. | *32618700* 32618700 | ||
PMC7314344 114. Incidence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients Receiving Prophylactic Anticoagulation. | *32618699* 32618699 | ||
PMC7314320 115. Thromboelastography Profiles of Critically Ill Patients With Coronavirus Disease 2019. | *32618696* 32618696 | ||
PMC7325395 116. Fatal Superimposed Bacterial Sepsis in a Healthy Coronavirus (COVID-19) Patient. | *32617223* 32617223 | ||
PMC7346299 117. Atypical Neurological Manifestations of COVID-19. | *32656033* 32656033 | ||
PMC7346295 118. A Predictive Model for Patient Census and Ventilator Requirements at Individual Hospitals During the Coronavirus Disease 2019 (COVID-19) Pandemic: A Preliminary Technical Report. | *32656017* 32656017 | ||
PMC7336594 119. Rare Presentation of Pulmonary Embolism Amidst Coronavirus Disease 2019 Era: Utility of Multiorgan Ultrasonography. | *32642364* 32642364 | ||
PMC7336650 120. A Fatal Case of Coronavirus Disease 2019 (COVID-19) in a Patient With Idiopathic Pulmonary Fibrosis. | *32642347* 32642347 | ||
PMC7336623 121. Acute Renal Failure in Critically Ill COVID-19 Patients With a Focus on the Role of Renal Replacement Therapy: A Review of What We Know So Far. | *32642345* 32642345 | ||
PMC7336683 122. A Review of Acute Myocardial Injury in Coronavirus Disease 2019. | *32642342* 32642342 | ||
PMC7325392 123. A Case of COVID-19 Infection With Delayed Thromboembolic Complication on Warfarin. | *32617244* 32617244 | ||
PMC7331779 124. Role of the Backbenchers of the Renin-Angiotensin System ACE2 and AT2 Receptors in COVID-19: Lessons From SARS. | *32626626* 32626626 | ||
PMC7348211 125. Acute Effusive Pericarditis: A Late Complication of COVID-19. | *32656050* 32656050 | ||
PMC7297161 126. Adipocytokines: Are they the Theory of Everything? | *32559663* 32559663 | ||
PMC7279707 127. The Impact of Novel Coronavirus on Dermatology. | *32551186* 32551186 | ||
PMC7319940 128. The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. | *32615377* 32615377 | ||
PMC7340587 129. Coronavirus lockdown effect on type 1 diabetes management omicronn children wearing insulin pump equipped with continuous glucose monitoring system. | *32650036* 32650036 | ||
PMC7294259 130. COVID-19-related thrombotic microangiopathy in a cirrhotic patient. | *32641274* 32641274 | ||
PMC7338398 131. How to Build the Plane While Flying: VTE/PE Thromboprophylaxis Clinical Guidelines for COVID-19 Patients. | *32613929* 32613929 | ||
PMC7259829 132. Novel coronavirus pneumonia and acute pulmonary thromboembolism: casualty or causality? | *32520072* 32520072 | ||
PMC7352095 133. Radiographic and chest CT imaging presentation and follow-up of COVID-19 pneumonia: a multicenter experience from an endemic area. | *32653961* 32653961 | ||
PMC7325211 134. Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management. | *32617120* 32617120 | ||
PMC7231757 135. Arterial thrombosis and coronavirus disease 2019 in a patient with cancer. | *32454394* 32454394 | ||
PMC7231735 136. Risk of coronavirus disease 2019 in patients treated for cancer: An immune response-based hypothesis. | *32425367* 32425367 | ||
PMC7320674 137. Is pregnancy a risk factor of COVID-19? | *32620513* 32620513 | ||
PMC7333606 138. Reply to correspondence: Vaginal delivery in a woman infected with SARS-CoV-2 - The first case reported in Portugal. | *32653231* 32653231 | ||
PMC7263061 139. The perils of premature phenotyping in COVID-19: a call for caution. | *32482788* 32482788 | ||
PMC7309749 140. Re: Hanbing Song, Bobak Seddighzadeh, Matthew R. Cooperberg, Franklin W. Huang. Expression of ACE2 and TMPRSS2, the SARS-CoV-2 Receptor and Co-Receptor, in Prostate Epithelial Cells. Eur Urol. In press DOI: 10.1016/j.eururo.2020.04.065. | *32624273* 32624273 | ||
PMC7303649 141. COVID-19-related Mortality During the First 60 Days After Kidney Transplantation. | *32624283* 32624283 | ||
PMC7311135 142. Atypical Presentation of COVID-19: Acute Renal Failure. | *32612435* 32612435 | ||
PMC7311134 143. Lessons Learned so Far from the Pandemic: A Review on Pregnants and Neonates with COVID-19. | *32612432* 32612432 | ||
PMC7256599 144. Assessment of SARS-CoV-2 in human semen-a cohort study. | *32650948* 32650948 | ||
PMC7287438 145. The jury is still out: COVID-19 and male reproduction. | *32650949* 32650949 | ||
PMC7324684 146. Re-positive Cases of Nucleic Acid Tests in Discharged Patients With COVID-19: A Follow-Up Study. | *32656223* 32656223 | ||
PMC7324794 147. Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study. | *32656222* 32656222 | ||
PMC7325892 148. Clinical Characteristics of COVID-19 Patients With Gastrointestinal Symptoms: An Analysis of Seven Patients in China. | *32656221* 32656221 | ||
PMC7317008 149. Strongly Heterogeneous Transmission of COVID-19 in Mainland China: Local and Regional Variation. | *32637423* 32637423 | ||
PMC7314898 150. ACE/ACE2 Ratio: A Key Also in 2019 Coronavirus Disease (Covid-19)? | *32626721* 32626721 | ||
PMC7308420 151. Strategy for Disease Diagnosis, Progression Prediction, Risk Group Stratification and Treatment-Case of COVID-19. | *32613004* 32613004 | ||
PMC7308495 152. Neuromechanisms of SARS-CoV-2: A Review. | *32612515* 32612515 | ||
PMC7324719 153. Coronaviruses and Central Nervous System Manifestations. | *32655490* 32655490 | ||
PMC7324652 154. A Contemporary Review of Neurological Sequelae of COVID-19. | *32655489* 32655489 | ||
PMC7314941 155. Potential of SARS-CoV-2 to Cause CNS Infection: Biologic Fundamental and Clinical Experience. | *32625165* 32625165 | ||
PMC7205675 156. Vitamin C and coronavirus. | *32439200* 32439200 | ||
PMC7301098 157. Vitamin D and Coronavirus. | *32591269* 32591269 | ||
PMC7330517 158. Standardized risk assessment and management of exposure amongst healthcare workers to coronavirus disease 2019. | *32656112* 32656112 | ||
PMC7218760 159. The Heart in the Time of the 'Coronavirus'. | *32489797* 32489797 | ||
PMC7301062 160. COVID-19 as a trigger of acute chest syndrome in a pregnant woman with sickle cell anemia. | *32646838* 32646838 | ||
PMC7301134 161. Hemodynamics, baroreflex index and blood biomarkers of a patient who died after being affected by COVID-19: case report. | *32646837* 32646837 | ||
PMC7293485 162. COVID-19 presenting as a viral exanthem and detected during admission prescreening in a hematopoietic cell transplant recipient. | *32646836* 32646836 | ||
PMC7165792 163. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. | *14767982* 14767982 | ||
PMC7165921 164. Severe acute respiratory syndrome and the liver. | *14767979* 14767979 | ||
PMC7292798 165. Absence of Evidence of Transmission of Coronavirus Disease 2019 from a Young Child to Mother Despite Prolonged Contact. | *32535688* 32535688 | ||
PMC7326396 166. Indicators of Critical Illness and Predictors of Mortality in COVID-19 Patients. | *32617010* 32617010 | ||
PMC7098314 167. Child-Turcotte-Pugh Score, MELD Score and MELD-Na Score as Predictors of Short-Term Mortality among Patients with End-Stage Liver Disease in Northern India. | *32232049* 32232049 | ||
PMC7228268 168. Uncertainties about the transmission routes of 2019 novel coronavirus. | *32129925* 32129925 | ||
PMC7262030 169. Olfactory dysfunction from acute upper respiratory infections: relationship to season of onset. | *32282136* 32282136 | ||
PMC7347496 170. Adaptation of Russian population to SARS-CoV-2: Asymptomatic course, comorbidities, mortality, and other respiratory viruses - A reply to Fear versus Data: Short Communication to International Journal of Antimicrobial Agents. | *32653618* 32653618 | ||
PMC7353830 171. Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic. | *32654049* 32654049 | ||
PMC7280648 172. SARS-Coronavirus-2 and acute urticaria. | *32441802* 32441802 | ||
PMC7305717 173. Rapidly fatal outcome of Covid-19 after successful emergency surgery during pandemic outbreak in Northern Italy. | *32622186* 32622186 | ||
PMC7340751 174. Role of frailty in COVID-19 patients. | *32638046* 32638046 | ||
PMC7272593 175. Learning from mistakes during the pandemic: the Lombardy lesson. | *32504102* 32504102 | ||
PMC7318906 176. Pulmonary embolism and screening for concomitant proximal deep vein thrombosis in noncritically ill hospitalized patients with coronavirus disease 2019. | *32592114* 32592114 | ||
PMC7344029 177. Characteristics and outcomes of Behcet's syndrome patients with Coronavirus Disease 2019: a case series of 10 patients. | *32647946* 32647946 | ||
PMC7333226 178. COVID-19 and elderly: beyond the respiratory drama. | *32621268* 32621268 | ||
PMC7331912 179. A COVID-19 patient with seven consecutive false-negative rRT-PCR results from sputum specimens. | *32617907* 32617907 | ||
PMC7330002 180. Bilateral lower limb weakness: a cerebrovascular consequence of covid-19 or a complication associated with it? | *32617903* 32617903 | ||
PMC7352087 181. COVID-19, coagulopathy and venous thromboembolism: more questions than answers. | *32653981* 32653981 | ||
PMC7348571 182. Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy. | *32651938* 32651938 | ||
PMC7273384 183. Zusammenhang zwischen Angiotensinblockade und Influenza-A-Inzidenz. | *32504298* 32504298 | ||
PMC7306741 184. Asthma and COVID: What Are the Important Questions? | *32585410* 32585410 | ||
PMC7345404 185. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma. | *32652231* 32652231 | ||
PMC7199726 186. Acute urticaria with angioedema in the setting of coronavirus disease 2019. | *32387383* 32387383 | ||
PMC7332433 187. New insights in COVID-19-associated chilblains: a comparative study with chilblain lupus erythematosus. | *32622895* 32622895 | ||
PMC7331500 188. The Risk of Respiratory Tract Infections in Psoriasis Patients Treated With IL-23-pathway Inhibiting Biologics: A Meta-Estimate of Pivotal Trials Relevant to Decision-Making During the COVID-19 Pandemic. | *32622891* 32622891 | ||
PMC7331510 189. The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries. | *32622888* 32622888 | ||
PMC7329682 190. Risk of COVID-19 in Dermatologic Patients on Long-term Immunomodulatory Therapy. | *32622141* 32622141 | ||
PMC7307985 191. Thromboembolism Prophylaxis for Patients Discharged From the Hospital: Easier Said Than Done. | *32586588* 32586588 | ||
PMC7228284 192. Frequency of arrhythmia in novel coronavirus 2019 infection. | *32426077* 32426077 | ||
PMC7212944 193. Recognizing Right Ventricular Dysfunction in Coronavirus Disease-2019-Related Respiratory Illness. | *32407800* 32407800 | ||
PMC7217795 194. Letter to Editor Reply: Therapeutic Strategy for Coronavirus Disease 2019 in Patients on Durable Left Ventricular Assist Device Support. | *32405231* 32405231 | ||
PMC7251401 195. Hematologic Consequences of the Coronavirus Crisis-Focus on Relevant Clues and Complications for the Perioperative Cardiothoracic and Vascular Community. | *32565045* 32565045 | ||
PMC7240264 196. Thromboelastometry and D-Dimer Elevation in Coronavirus-2019. | *32593588* 32593588 | ||
PMC7295490 197. Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia. | *32653497* 32653497 | ||
PMC7331864 198. Life-Threatening Psoas Hematoma due to Retroperitoneal Hemorrhage in a COVID-19 Patient on Enoxaparin Treated With Arterial Embolization: A Case Report. | *32655742* 32655742 | ||
PMC7331863 199. The Impact of COVID-19 Global Pandemic on Morbidity and Mortality of Liver Transplant Recipients Children and Adults: A Systematic Review of Case Series. | *32655733* 32655733 | ||
PMC7335765 200. First, do no harm: bilateral radial artery occlusion in a COVID-19 patient. | *32632667* 32632667 | ||
PMC7103464 201. National common metrics for the NIH Clinical and Translational Science Award Institutions: A signal of the transformation of the American biomedical research enterprise. | *32257403* 32257403 | ||
PMC7323648 202. Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes. | *32636061* 32636061 | ||
PMC7336933 203. COVID-19 in people living with diabetes: An international consensus. | *32651031* 32651031 | ||
PMC7272961 204. Urticarial eruption in coronavirus disease 2019 infection: a case report in Tangerang, Indonesia. | *32386435* 32386435 | ||
PMC7326390 205. A focused review on the genital and sexual affection of COVID-19 patients. | *32619728* 32619728 | ||
PMC7236846 206. Hypertension and coronavirus disease 2019 mortality. | *32371818* 32371818 | ||
PMC7236850 207. Hypertension and predisposition to infection: an important issue during this global pandemic. | *32371816* 32371816 | ||
PMC7236840 208. Hypertension and coronavirus disease 2019: what do we really know? | *32371815* 32371815 | ||
PMC7282406 209. Hyperreninemia and low total body water may contribute to acute kidney injury in COVID-19 patients in intensive care. | *32472780* 32472780 | ||
PMC7324335 210. Cardiac injury and mortality in COVID-19: A reappraisal. | *32615200* 32615200 | ||
PMC7342089 211. Oscillation of SARS CoV-2 RNA load in a cohort of children and adolescents with neuro-psychiatric disorders resident in a nursing home of Lombardy Region (Italy). | *32652168* 32652168 | ||
PMC7342032 212. COVID-19: Outcomes of patients with confirmed COVID-19 re-admitted to hospital. | *32652166* 32652166 | ||
PMC7342079 213. Clinical features and outcomes of adult COVID-19 patients co-infected with Mycoplasma pneumoniae. | *32652163* 32652163 | ||
PMC7334925 214. A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis. | *32634459* 32634459 | ||
PMC7333627 215. Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics. | *32628960* 32628960 | ||
PMC7328613 216. Prolonged presence of SARS-CoV-2 in a COVID-19 case with rheumatoid arthritis taking iguratimod treated with ciclesonide. | *32631736* 32631736 | ||
PMC7306724 217. Co-infection of MERS-CoV and SARS-CoV-2 in the same host: A silent threat. | *32622797* 32622797 | ||
PMC7328583 218. An unusual case of coronavirus disease 2019: Delayed chest CT evidence. | *32636075* 32636075 | ||
PMC7166603 219. Diffusion-weighted MR study of femoral head avascular necrosis in severe acute respiratory syndrome patients. | *16193472* 16193472 | ||
PMC7272937 220. Acute kidney injury is associated with the mortality of coronavirus disease 2019. | *32410212* 32410212 | ||
PMC7228413 221. Coronavirus uses as binding site in humans angiotensin-converting enzyme 2 functional receptor that is involved in arterial blood pressure control and fibrotic response to damage and is a drug target in cardiovascular disease. Is this just a phylogenetic coincidence? | *32216172* 32216172 | ||
PMC7087661 222. The 2019 novel cornoavirus pneumonia with onset of oculomotor nerve palsy: a case study. | *32100124* 32100124 | ||
PMC7319640 223. Potential underlying mechanisms of cerebral venous thrombosis associated with COVID-19. | *32620231* 32620231 | ||
361. Hypertension and diabetes mellitus in patients with COVID 19: a viewpoint on mortality. | *C7299096* C7299096 | ||
362. The Impact of COVID-19 on Cancer Risk and Treatment. | *C7323371* C7323371 | ||
363. Clinical and Imaging Features of COVID-19 in a Neonate. | *32654740* 32654740 | ||
364. LUNG TRANSPLANTATION FOR AN ARDS PATIENT POST-COVID-19 INFECTION. | *C7315157* C7315157 | ||
365. 2019 novel-coronavirus: Cardiovascular insights about risk factors myocardial injury therapy and clinical implications. | *C7293466* C7293466 | ||
366. Cardiac Injury and COVID-19: A Systematic Review and Meta-Analysis. | *C7308771* C7308771 | ||
367. Acute myopericarditis in a patient with mild SARS-CoV2 respiratory infection. | *C7305884* C7305884 | ||
368. COVID-19 and Myocarditis: What Do We Know So Far? | *C7254016* C7254016 | ||
369. Severe acute respiratory syndrome coronavirus 2 as an atypical cause of Bell s palsy in a patient experiencing homelessness. | *C7306549* C7306549 | ||
370. Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection after allogeneic stem cell transplantation. | *C7307077* C7307077 | ||
371. Paraviral eruptions in the era of COVID-19: Do some skin manifestations point to a natural resistance to SARS-CoV-2? | *C7293526* C7293526 | ||
372. Addendum to: Eruption as a clinical manifestation of COVID-19: Photographs of a patient. | *C7290195* C7290195 | ||
373. Could injured skin be a reservoir for SARS-COV2 virus spread?☆. | *C7282737* C7282737 | ||
374. COVID toes or pernio? | *C7273145* C7273145 | ||
375. A case for palliative dermatology: COVID-19–related dermatoses. | *C7273135* C7273135 | ||
376. Eruption as a clinical manifestation of COVID-19: photographs of a patient. | *C7251999* C7251999 | ||
377. Reply to Clinical characteristics of COVID-19 in patients with liver injury. | *C7351069* C7351069 | ||
378. Encephalopathy as neurological involvement of SARS-COV-2 infection. | *C7319622* C7319622 | ||
379. El suplemento con altas dosis de vitamina D podría representar una alternativa promisoria para prevenir o tratar la infección por COVID-19. | *C7256522* C7256522 | ||
380. Acute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury. | *C7337686* C7337686 | ||
381. Severe acute respiratory SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience. | *C7337639* C7337639 | ||
382. Clinical outcomes of hemodialysis patients infected with severe acute respiratory syndrome coronavirus 2 and impact of proactive chest computed tomography scans. | *C7314250* C7314250 | ||
383. Coronavirus disease 2019: acute Fanconi syndrome precedes acute kidney injury. | *C7314200* C7314200 | ||
384. Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019. | *C7314187* C7314187 | ||
385. A brand-new cardiorenal syndrome in the Coronavirus Disease- 2019 (COVID-19) setting. | *C7314230* C7314230 | ||
386. Indirect effects of severe acute respiratory syndrome coronavirus 2 on the kidney in coronavirus disease patients. | *C7314263* C7314263 | ||
387. The syndrome of inappropriate antidiuresis in COVID-19 pneumonia: report of two cases. | *C7239248* C7239248 | ||
388. Kidney manifestations of mild moderate and severe coronavirus disease 2019: a retrospective cohort study. | *C7239220* C7239220 | ||
389. Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients. | *32659385* 32659385 | ||
390. Electroencephalographic (EEG) features of encephalopathy in the setting of Covid-19: A Case Series. | *C7329683* C7329683 | ||
391. Mechanical thrombectomy for acute ischaemic stroke during the COVID-19 pandemic: changes to UK practice and lessons learned. | *32682524* 32682524 | ||
392. Extent of pulmonary thromboembolic disease in patients with COVID-19 on CT: relationship with pulmonary parenchymal disease. | *32684301* 32684301 | ||
393. Collateral damage: Fear from SARS-CoV2-infection causing Takotsubo cardiomyopathy. | *32661675* 32661675 | ||
394. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. | *32660650* 32660650 | ||
395. Neurological manifestations of COVID-19: a systematic review. | *32660520* 32660520 | ||
396. Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO. | *32660540* 32660540 | ||
397. Gender Difference Is Associated With Severity of Coronavirus Disease 2019 Infection: An Insight From a Meta-Analysis. | *32696011* 32696011 | ||
398. Acute Limb Ischemia Due to Arterial Thrombosis Associated With Coronavirus Disease 2019. | *32696003* 32696003 | ||
399. Frequency of Continuous Renal Replacement Therapy Use Early in Coronavirus Disease 2019 Pandemic. | *32671352* 32671352 | ||
400. Critical Care Clinician Reports on Coronavirus Disease 2019: Results From a National Survey of 4 875 ICU Providers. | *32671350* 32671350 | ||
401. Disrupting the Electrical Circuit: New Onset Atrial Fibrillation in a Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). | *32670726* 32670726 | ||
402. Herpes Zoster Co-Infection in an Immunocompetent Patient With COVID-19. | *32670724* 32670724 | ||
403. Coronavirus Disease 2019 (COVID-19)-Associated Thromboembolic Disease: A Report of Three Patients With Pulmonary Embolism. | *32670718* 32670718 | ||
404. SARS-CoV-2 (COVID 19) Infection in Hypertensive Patients and in Patients With Cardiac Disease. | *32670694* 32670694 | ||
405. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Induced Cardiovascular Syndrome: Etiology Outcomes and Management. | *32670680* 32670680 | ||
406. Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients. | *32703535* 32703535 | ||
407. Transverse leukonychia (Mees’ lines) nail alterations in a COVID‐19 patient. | *C7323062* C7323062 | ||
408. Hypoglycemia at the time of Covid-19 pandemic. | *32668399* 32668399 | ||
409. Association of hypertension diabetes stroke cancer kidney disease and high-cholesterol with COVID-19 disease severity and fatality: A systematic review. | *32663789* 32663789 | ||
410. BMI and future risk for COVID-19 infection and death across sex age and ethnicity: Preliminary findings from UK biobank. | *32668401* 32668401 | ||
411. A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19. | *32663490* 32663490 | ||
412. Comment on “Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus”. | *32663491* 32663491 | ||
413. Diabetes and Novel Coronavirus Infection: Implications for Treatment. | *32661881* 32661881 | ||
414. Children and Fecal SARS-CoV-2 shedding: Just the tip of the Iceberg of Italian COVID-19 outbreak? | *32690380* 32690380 | ||
415. Sex differences in the relationship between digit ratio (2D:4D) and national case fatality rates for COVID-19: A reply to Sahin (2020). | *32659609* 32659609 | ||
416. Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort. | *C7338015* C7338015 | ||
417. Characteristics risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait. | *C7335246* C7335246 | ||
418. SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes. | *C7334039* C7334039 | ||
419. Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain. | *C7295514* C7295514 | ||
420. Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10 898 patients and proposal of a triage risk stratification tool. | *32661796* 32661796 | ||
421. High-resolution computed tomography finding in 552 patients with symptomatic COVID-19: first report from north of Iran. | *32661945* 32661945 | ||
422. Acute hypothermia in Covid 19: A case report. | *C7305886* C7305886 | ||
423. Large vessel stroke and COVID-19: Case report and literature review. | *C7297179* C7297179 | ||
424. Recomendaciones para el manejo del paciente con enfermedad renal crónica ante el SARS-CoV-2. | *C7245305* C7245305 | ||
425. Dyspnea and pleuritic chest pain during the COVID-19 pandemic. | *32693947* 32693947 | ||
426. Clinical Characteristics and Outcomes of Type 2 Diabetes Patients Infected with COVID-19: A Retrospective Study. | *C7320669* C7320669 | ||
427. Functional and cognitive outcomes after COVID-19 delirium. | *32666303* 32666303 | ||
428. Concealed SARS-CoV-2 interstitial pneumonia unmasked by infarct-like acute myocarditis. | *C7314076* C7314076 | ||
429. Subacute perimyocarditis in a young patient with COVID-19 infection. | *C7314082* C7314082 | ||
430. Case report of anterior ST-elevation myocardial infarction in a patient with coronavirus disease-2019. | *C7314176* C7314176 | ||
431. Atherosclerotic spontaneous coronary artery dissection (A-SCAD) in a patient with COVID-19: case report and possible mechanisms. | *C7239234* C7239234 | ||
432. Novel coronavirus 19 (COVID-19) associated sinus node dysfunction: a case series. | *C7239209* C7239209 | ||
361. Hypertension and diabetes mellitus in patients with COVID 19: a viewpoint on mortality. | *C7299096* C7299096 | ||
362. The Impact of COVID-19 on Cancer Risk and Treatment. | *C7323371* C7323371 | ||
363. Clinical and Imaging Features of COVID-19 in a Neonate. | *32654740* 32654740 | ||
364. LUNG TRANSPLANTATION FOR AN ARDS PATIENT POST-COVID-19 INFECTION. | *C7315157* C7315157 | ||
365. 2019 novel-coronavirus: Cardiovascular insights about risk factors myocardial injury therapy and clinical implications. | *C7293466* C7293466 | ||
366. Cardiac Injury and COVID-19: A Systematic Review and Meta-Analysis. | *C7308771* C7308771 | ||
367. Acute myopericarditis in a patient with mild SARS-CoV2 respiratory infection. | *C7305884* C7305884 | ||
368. COVID-19 and Myocarditis: What Do We Know So Far? | *C7254016* C7254016 | ||
369. Severe acute respiratory syndrome coronavirus 2 as an atypical cause of Bell s palsy in a patient experiencing homelessness. | *C7306549* C7306549 | ||
370. Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection after allogeneic stem cell transplantation. | *C7307077* C7307077 | ||
371. Paraviral eruptions in the era of COVID-19: Do some skin manifestations point to a natural resistance to SARS-CoV-2? | *C7293526* C7293526 | ||
372. Addendum to: Eruption as a clinical manifestation of COVID-19: Photographs of a patient. | *C7290195* C7290195 | ||
373. Could injured skin be a reservoir for SARS-COV2 virus spread?☆. | *C7282737* C7282737 | ||
374. COVID toes or pernio? | *C7273145* C7273145 | ||
375. A case for palliative dermatology: COVID-19–related dermatoses. | *C7273135* C7273135 | ||
376. Eruption as a clinical manifestation of COVID-19: photographs of a patient. | *C7251999* C7251999 | ||
377. Reply to Clinical characteristics of COVID-19 in patients with liver injury. | *C7351069* C7351069 | ||
378. Encephalopathy as neurological involvement of SARS-COV-2 infection. | *C7319622* C7319622 | ||
379. El suplemento con altas dosis de vitamina D podría representar una alternativa promisoria para prevenir o tratar la infección por COVID-19. | *C7256522* C7256522 | ||
380. Acute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury. | *C7337686* C7337686 | ||
381. Severe acute respiratory SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience. | *C7337639* C7337639 | ||
382. Clinical outcomes of hemodialysis patients infected with severe acute respiratory syndrome coronavirus 2 and impact of proactive chest computed tomography scans. | *C7314250* C7314250 | ||
383. Coronavirus disease 2019: acute Fanconi syndrome precedes acute kidney injury. | *C7314200* C7314200 | ||
384. Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019. | *C7314187* C7314187 | ||
385. A brand-new cardiorenal syndrome in the Coronavirus Disease- 2019 (COVID-19) setting. | *C7314230* C7314230 | ||
386. Indirect effects of severe acute respiratory syndrome coronavirus 2 on the kidney in coronavirus disease patients. | *C7314263* C7314263 | ||
387. The syndrome of inappropriate antidiuresis in COVID-19 pneumonia: report of two cases. | *C7239248* C7239248 | ||
388. Kidney manifestations of mild moderate and severe coronavirus disease 2019: a retrospective cohort study. | *C7239220* C7239220 | ||
389. Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients. | *32659385* 32659385 | ||
390. Electroencephalographic (EEG) features of encephalopathy in the setting of Covid-19: A Case Series. | *C7329683* C7329683 | ||
391. Mechanical thrombectomy for acute ischaemic stroke during the COVID-19 pandemic: changes to UK practice and lessons learned. | *32682524* 32682524 | ||
392. Extent of pulmonary thromboembolic disease in patients with COVID-19 on CT: relationship with pulmonary parenchymal disease. | *32684301* 32684301 | ||
393. Collateral damage: Fear from SARS-CoV2-infection causing Takotsubo cardiomyopathy. | *32661675* 32661675 | ||
394. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. | *32660650* 32660650 | ||
395. Neurological manifestations of COVID-19: a systematic review. | *32660520* 32660520 | ||
396. Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO. | *32660540* 32660540 | ||
397. Gender Difference Is Associated With Severity of Coronavirus Disease 2019 Infection: An Insight From a Meta-Analysis. | *32696011* 32696011 | ||
398. Acute Limb Ischemia Due to Arterial Thrombosis Associated With Coronavirus Disease 2019. | *32696003* 32696003 | ||
399. Frequency of Continuous Renal Replacement Therapy Use Early in Coronavirus Disease 2019 Pandemic. | *32671352* 32671352 | ||
400. Critical Care Clinician Reports on Coronavirus Disease 2019: Results From a National Survey of 4 875 ICU Providers. | *32671350* 32671350 | ||
401. Disrupting the Electrical Circuit: New Onset Atrial Fibrillation in a Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). | *32670726* 32670726 | ||
402. Herpes Zoster Co-Infection in an Immunocompetent Patient With COVID-19. | *32670724* 32670724 | ||
403. Coronavirus Disease 2019 (COVID-19)-Associated Thromboembolic Disease: A Report of Three Patients With Pulmonary Embolism. | *32670718* 32670718 | ||
404. SARS-CoV-2 (COVID 19) Infection in Hypertensive Patients and in Patients With Cardiac Disease. | *32670694* 32670694 | ||
405. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Induced Cardiovascular Syndrome: Etiology Outcomes and Management. | *32670680* 32670680 | ||
406. Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients. | *32703535* 32703535 | ||
407. Transverse leukonychia (Mees’ lines) nail alterations in a COVID‐19 patient. | *C7323062* C7323062 | ||
408. Hypoglycemia at the time of Covid-19 pandemic. | *32668399* 32668399 | ||
409. Association of hypertension diabetes stroke cancer kidney disease and high-cholesterol with COVID-19 disease severity and fatality: A systematic review. | *32663789* 32663789 | ||
410. BMI and future risk for COVID-19 infection and death across sex age and ethnicity: Preliminary findings from UK biobank. | *32668401* 32668401 | ||
411. A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19. | *32663490* 32663490 | ||
412. Comment on “Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus”. | *32663491* 32663491 | ||
413. Diabetes and Novel Coronavirus Infection: Implications for Treatment. | *32661881* 32661881 | ||
414. Children and Fecal SARS-CoV-2 shedding: Just the tip of the Iceberg of Italian COVID-19 outbreak? | *32690380* 32690380 | ||
415. Sex differences in the relationship between digit ratio (2D:4D) and national case fatality rates for COVID-19: A reply to Sahin (2020). | *32659609* 32659609 | ||
416. Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort. | *C7338015* C7338015 | ||
417. Characteristics risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait. | *C7335246* C7335246 | ||
418. SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes. | *C7334039* C7334039 | ||
419. Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain. | *C7295514* C7295514 | ||
420. Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10 898 patients and proposal of a triage risk stratification tool. | *32661796* 32661796 | ||
421. High-resolution computed tomography finding in 552 patients with symptomatic COVID-19: first report from north of Iran. | *32661945* 32661945 | ||
422. Acute hypothermia in Covid 19: A case report. | *C7305886* C7305886 | ||
423. Large vessel stroke and COVID-19: Case report and literature review. | *C7297179* C7297179 | ||
424. Recomendaciones para el manejo del paciente con enfermedad renal crónica ante el SARS-CoV-2. | *C7245305* C7245305 | ||
425. Dyspnea and pleuritic chest pain during the COVID-19 pandemic. | *32693947* 32693947 | ||
426. Clinical Characteristics and Outcomes of Type 2 Diabetes Patients Infected with COVID-19: A Retrospective Study. | *C7320669* C7320669 | ||
427. Functional and cognitive outcomes after COVID-19 delirium. | *32666303* 32666303 | ||
428. Concealed SARS-CoV-2 interstitial pneumonia unmasked by infarct-like acute myocarditis. | *C7314076* C7314076 | ||
429. Subacute perimyocarditis in a young patient with COVID-19 infection. | *C7314082* C7314082 | ||
430. Case report of anterior ST-elevation myocardial infarction in a patient with coronavirus disease-2019. | *C7314176* C7314176 | ||
431. Atherosclerotic spontaneous coronary artery dissection (A-SCAD) in a patient with COVID-19: case report and possible mechanisms. | *C7239234* C7239234 | ||
432. Novel coronavirus 19 (COVID-19) associated sinus node dysfunction: a case series. | *C7239209* C7239209 | ||
433. Fingolimod: Lymphopenia and COVID-19 infection complicated by pneumonia: case report. | *C7348128* C7348128 | ||
434. Rapidly progressive COVID-19 viral pneumonia: a report of two patients with a focus on imaging findings. | *C7296529* C7296529 | ||
435. Whither are we bound? Rethinking the gendered frailty during COVID-19 pandemic. | *C7287439* C7287439 | ||
436. Zerebrovaskuläre Komplikationen bei Patienten mit COVID-19 . | *C7264966* C7264966 | ||
437. Peste noire (1347â1352) et Covid-19 (2019â20--Â ?) 1. Les similitudes. | *C7245325* C7245325 | ||
438. Vitamin D and SARS-CoV-2 virus/COVID-19 disease. | *C7246103* C7246103 | ||
439. Neurologische Auswirkungen von COVID-19. | *C7212508* C7212508 | ||
440. Guillain-Barré syndrome associated with SARS-CoV-2 infection☆. | *C7205632* C7205632 | ||
441. Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: A delayed pandemic?? | *C7205729* C7205729 | ||
442. Fatal Guillain-Barre syndrome after infection with SARS-CoV-2☆. | *C7205695* C7205695 | ||
443. Chilblain and Acral Purpuric Lesions in Spain during Covid Confinement: Retrospective Analysis of 12 Cases☆. | *32402369* 32402369 | ||
444. COVID-19 and Hypertension: The Role of ACE2 and the Renin-Angiotensin System. | *C7334971* C7334971 | ||
445. Expert consensus on protocol of rehabilitation for COVID‐19 patients using framework and approaches of WHO International Family Classifications. | *32666026* 32666026 | ||
446. Cardiac Involvment in COVID-19–Related Acute Respiratory Distress Syndrome. | *C7355325* C7355325 | ||
447. Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed with COVID-19. | *C7354276* C7354276 | ||
448. Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction. | *C7333635* C7333635 | ||
449. Prognostic Value of Left Ventricular Global Longitudinal Strain in COVID-19. | *C7332458* C7332458 | ||
450. Prevalence and Outcomes of Acute Ischemic Stroke Among Patients ≤50 Years of Age With Laboratory Confirmed COVID-19 Infection. | *32690214* 32690214 | ||
451. Bilateral spontaneous pneumothorax in SARS-CoV-2 infection: A very rare life-threatening complication. | *C7354379* C7354379 | ||
452. Effect of heart failure on the outcome of COVID-19 — A meta analysis and systematic review. | *C7347316* C7347316 | ||
453. A case report of possible novel coronavirus 2019 reinfection. | *32703607* 32703607 | ||
454. The conundrum of rising Covid19 infection among health care workers: An emerging paradigm. | *C7335236* C7335236 | ||
455. Priapism in a patient with coronavirus disease 2019 (COVID-19): A case report. | *C7301054* C7301054 | ||
456. Dermatologic manifestations and complications of COVID-19. | *C7274995* C7274995 | ||
457. Psychological Distress and Its Correlates Among COVID-19 Survivors During Early Convalescence Across Age Groups. | *C7347493* C7347493 | ||
458. Prevalence of Comorbidities Among Individuals With COVID-19: A Rapid Review of current Literature. | *32659414* 32659414 | ||
459. The diagnoses and outcomes of emergency patients with an elevated D-dimer over the next 90 days. | *32663451* 32663451 | ||
460. Association of COVID-19 with Anosmia and Hypogeusia. | *32703532* 32703532 | ||
461. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. | *C7308019* C7308019 | ||
462. Recovery rate and factors associated with smell and taste disruption in patients with coronavirus disease 2019. | *C7358151* C7358151 | ||
463. Subjective smell and taste changes during the COVID-19 pandemic: Short term recovery. | *32682192* 32682192 | ||
464. Disparities in COVID-19 Testing and Positivity in New York City. | *32703702* 32703702 | ||
465. ICU outcomes of COVID-19 critically ill patients: An international comparative study. | *32654909* 32654909 | ||
466. Characteristics of critically ill patients infected with COVID-19 in Abu Dhabi United Arab Emirates. | *32660852* 32660852 | ||
467. COVID-19 Seroconversion in Emergency Professionals at an Urban Academic Emergency Department in New York City. | *C7306730* C7306730 | ||
468. Prevalence of positive COVID-19 among asymptomatic health care workers who care patients infected with the novel coronavirus: A retrospective study. | *C7351662* C7351662 | ||
469. COVID-19 gastrointestinal symptoms mimicking surgical presentations. | *32632349* 32632349 | ||
470. Characteristics of venous thromboembolism in COVID-19 patients: a multicenter experience from Northern Italy. | *32673648* 32673648 | ||
471. Neumomediastino espontáneo en pacientes con COVID-19: una serie de cuatro casos. | *C7334953* C7334953 | ||
472. Biologic Therapy in COVID-19. | *32654852* 32654852 | ||
473. Age Matters but it should not be Used to Discriminate Against the Elderly in Allocating Scarce Resources in the Context of COVID-19. | *C7298697* C7298697 | ||
474. Male genital damage in COVID-19 patients: Are available data relevant? | *C7306201* C7306201 | ||
475. Asintomáticos Covid 19 excluidos de protocolos. | *C7346817* C7346817 | ||
476. Prevención e identificación temprana de casos sospechosos COVID-19 en el primer nivel de atención en Centro América. | *C7293519* C7293519 | ||
477. COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Fran"aise SALF). | *C7355134* C7355134 | ||
478. Concomitant infection with COVID-19 and Mycoplasma pneumoniae. | *C7358157* C7358157 | ||
479. Is there an association between oral health and severity of COVID-19 complications? | *C7258848* C7258848 | ||
480. Clinical characteristics of patients diagnosed with COVID-19 in Beijing. | *C7217107* C7217107 | ||
481. Interplay between platelets and coagulation. | *32682574* 32682574 | ||
482. Age source and future risk of COVID-19 infections in two settings of Hong Kong and Singapore. | *32660556* 32660556 | ||
483. Erythema nodosum as a cutaneous manifestation of COVID-19 infection. | *32641310* 32641310 | ||
484. Lung cavitation due to COVID-19 pneumonia. | *32636231* 32636231 | ||
485. Coinfection with SARS-CoV-2 and influenza A virus. | *32611659* 32611659 | ||
486. 4-month-old boy coinfected with COVID-19 and adenovirus. | *32606105* 32606105 | ||
487. No evidence of vertical transmission of SARS-CoV-2 after induction of labour in an immune-suppressed SARS-CoV-2-positive patient. | *32606133* 32606133 | ||
488. Cerebrovascular disease in COVID-19: Is there a higher risk of stroke? | *C7297683* C7297683 | ||
489. Acute transverse myelitis associated with SARS-CoV-2: A Case-Report. | *C7275168* C7275168 | ||
490. The cognitive consequences of the COVID-19 epidemic: collateral damage? | *C7314157* C7314157 | ||
491. The cognitive aftermath of COVID-19. | *C7314202* C7314202 | ||
492. Follow-up of convalescent COVID-19 patients by the general practitioner. | *C7354252* C7354252 | ||
493. Follow-up of caregivers involved in the management of COVID-19. | *C7354267* C7354267 | ||
494. A blind spot in the Covid-19 epidemic: Nosocomial transmission to healthcare workers. | *C7234784* C7234784 | ||
495. Retrospective Analysis of 2019-nCov-Infected Cases in Dongyang Southeastern China. | *32670441* 32670441 | ||
496. Multiorgan Failure With Emphasis on Acute Kidney Injury and Severity of COVID-19: Systematic Review and Meta-Analysis. | *C7343353* C7343353 | ||
497. SARS-CoV-2 and cancer: Are they really partners in crime? | *C7351667* C7351667 | ||
498. Obese communities among the best predictors of COVID-19-related deaths. | *C7314342* C7314342 | ||
499. Fatal Pulmonary Thromboembolism in SARS-CoV-2-Infection. | *C7214296* C7214296 | ||
500. A Case of Hemorrhagic Cardiac Tamponade in a Patient with COVID-19 Infection. | *C7269928* C7269928 | ||
501. Atypical Presentation of COVID-19 Leading to ARDS. | *32670643* 32670643 | ||
502. Fetal deaths in pregnancies with SARS-CoV-2 infection in Brazil: A case series. | *C7354271* C7354271 | ||
503. Obstetric and intensive-care strategies in a high-risk pregnancy with critical respiratory failure due to COVID-19: A case report. | *C7340590* C7340590 | ||
504. Possible formation of pulmonary microthrombi in the early puerperium of pregnant women critically ill with COVID-19: Two case reports. | *C7320266* C7320266 | ||
505. Immunosuppressants: Coronavirus-2019 infection: 15 case reports. | *C7348101* C7348101 | ||
506. Severe SARS-CoV-2 infection in critical care. | *C7351661* C7351661 | ||
507. Natalizumab: Pneumonia caused by COVID-19: case report. | *C7348122* C7348122 | ||
508. Enoxaparin-sodium: Intracranial haemorrhage: case report. | *C7348119* C7348119 | ||
509. A case of COVID-19 lung infection in a non-febrile woman followed for mantle cell lymphoma. | *C7346826* C7346826 | ||
510. Hepatic manifestations and impact of COVID-19 on the cirrhotic patient☆. | *C7346816* C7346816 | ||
511. Nierenkranke stark gefährdet. | *C7326760* C7326760 | ||
512. Emerging patterns of hypercoagulability associated with critical COVID-19: A review. | *C7346831* C7346831 | ||
513. SARS-CoV-2 nun doch in Sperma nachgewiesen. | *C7326759* C7326759 | ||
514. COVID -19 and sudden sensorineural hearing loss a case report. | *C7342036* C7342036 | ||
515. Recovering from COVID-19: the key issues. | *C7341029* C7341029 | ||
516. Multiple drugs: COVID-19 infection: 4 case reports. | *C7334112* C7334112 | ||
517. Síndrome DRESS en paciente con enfermedad por SARS-CoV-2. | *C7334950* C7334950 | ||
518. Alteplase/heparin/low-molecular-weight-heparins: Lack of efficacy femoral haemorrhage and jugular haemorrhage: 5 case reports. | *C7334113* C7334113 | ||
519. Nivolumab: Paradoxical immunologic response in the form of COVID-19: case report. | *C7334111* C7334111 | ||
520. Estimating the Impact of Covid-19 Outbreak on High-Risk Age Group Population in India. | *C7327483* C7327483 | ||
521. Hohes Mortalitätsrisiko bei Diabetespatienten mit COVID-19. | *C7302938* C7302938 | ||
522. Adipositas begünstigt einen schweren COVID-19-Verlauf. | *C7302936* C7302936 | ||
523. Angiotensin II suppression in SARS-CoV-2 infection: a therapeutic approach☆. | *C7323640* C7323640 | ||
524. An unusual case of severe acute hyponatremia in patient with COVID-19 infection☆. | *C7323635* C7323635 | ||
525. Immunosuppressants: COVID-19 pneumonia: 10 case reports. | *C7317073* C7317073 | ||
526. Komorbiditäten und ACE-Hemmer-Therapie. | *C7291611* C7291611 | ||
527. Erhöhtes Schlaganfallrisiko bei COVID-19. | *C7291618* C7291618 | ||
528. Läsionen bei jedem fünften Patienten: COVID-19 und Haut. | *C7287290* C7287290 | ||
529. Gastrointestinale Manifestation und fäkale Viruslast der SARS-CoV-2-Infektion. | *C7275650* C7275650 | ||
530. Antineoplastics: Drug induced lung injury oral ulcer and viral pneumonia: 2 case reports. | *C7303436* C7303436 | ||
531. Immunosuppressants: COVID-2019 infections: 7 case reports. | *C7303431* C7303431 | ||
532. Inhibidores de la enzima convertidora de angiotensina y bloqueadores de los receptores de angiotensina II: ¿aumentan el riesgo de padecer COVID-19? | *C7290183* C7290183 | ||
533. Report of a patient with neurological symptoms as the sole manifestation of SARS-CoV-2 infection☆. | *C7241341* C7241341 | ||
534. Hepatobiliary and Pancreatic Manifestations of Coronavirus Disease 2019. | *C7295265* C7295265 | ||
535. Risk of Covid-19 with renin-angiotensin-aldosterone system medications. | *C7232911* C7232911 | ||
536. Two outbreaks of SARS-CoV-2 in department of surgery in a Wuhan hospital. | *C7227536* C7227536 | ||
537. Cas d’une patiente de grand âge en hospitalisation aiguë pour une atteinte sévère de COVID-19 : aspects moteurs. | *C7225697* C7225697 | ||
538. Cardiac complications in community-acquired pneumonia and COVID-19. | *C7221539* C7221539 | ||
539. Positive SARS-Cov-2 test in a woman with COVID-19 at 22 days after hospital discharge: A case report. | *C7144858* C7144858 | ||
540. Should ACE Inhibitors and Angiotensin Receptor Blockers Be Withdrawn in the Current Setting of COVID-19 Infection? | *C7187740* C7187740 | ||
541. When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality? | *C7323660* C7323660 | ||
PMC7323828 225. Delayed Diagnosis of Postintubation Tracheal Stenosis due to the Coronavirus Disease 2019 Pandemic: A Case Report. | *32643909* 32643909 | ||
PMC7304537 226. Gastrointestinal Findings in a Patient With COVID-19. | *32637437* 32637437 | ||
PMC7353822 227. Type 1 diabetes onset triggered by COVID-19. | *32653960* 32653960 | ||
PMC7239780 228. Lesiones pernioticas y acrales en Espana durante el confinamiento por COVID: analisis retrospectivo de 12 casos. | *32402369* 32402369 | ||
PMC7291942 229. Raising awareness of the needs of older COVID patients after hospital discharge. | *32533501* 32533501 | ||
PMC7309642 230. Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV. | *32501852* 32501852 | ||
PMC7278301 231. Role of Olfaction in Human Health: A Focus on Coronaviruses. | *32551179* 32551179 | ||
PMC7282749 232. Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19. | *32636018* 32636018 | ||
PMC7280141 233. The Right Ventricle in COVID-19 Patients. | *32624188* 32624188 | ||
PMC7266568 234. A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19. | *32624189* 32624189 | ||
PMC7343906 235. Dermatologists' Role in the Diagnosis and Management of Coronavirus Disease 2019 Coagulopathy. | *32648107* 32648107 | ||
PMC7320680 236. COVID-19 associated parotitis: A case report. | *32631770* 32631770 | ||
PMC7308738 237. Letter to the editor: Neuroleptic malignant syndrome in COVID-19 patients by Soh et al. | *32650958* 32650958 | ||
PMC7273934 238. Peptic Ulcer Disease as a Common Cause of Bleeding in Patients with Coronavirus Disease 2019. | *32453051* 32453051 | ||
PMC7345482 239. "Clinical Characteristics, Outcomes and Prognosticators in Adult Patients Hospitalized with COVID-19". | *32652252* 32652252 | ||
PMC7236709 240. Racial Inequalities in Mortality from Coronavirus: The Tip of the Iceberg. | *32442516* 32442516 | ||
PMC7350644 241. The Relationship between Diabetes Mellitus and COVID-19 Prognosis: A Retrospective Cohort Study in Wuhan, China. | *32653423* 32653423 | ||
PMC7347494 242. Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era. | *32653420* 32653420 | ||
PMC7309902 243. Ear nose throat-related symptoms with a focus on loss of smell and/or taste in COVID-19 patients. | *32629147* 32629147 | ||
PMC7288789 244. Is Angiotensin II Unopposed a Good Thing? | *32502133* 32502133 | ||
PMC7211613 245. Clinical course of asthma in 4 cases of coronavirus disease 2019 infection. | *32437838* 32437838 | ||
PMC7297691 246. Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York. | *32648546* 32648546 | ||
PMC7304657 247. Update Alert: Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers. | *32515983* 32515983 | ||
PMC7320852 248. SURGICAL RESECTIONS OF SUPERINFECTED PNEUMATOCELES IN A COVID-19 PATIENT. | *32603707* 32603707 | ||
PMC7333133 249. A retrospective analysis of the epidemiology, clinical manifestations, and imaging characteristics of familial cluster-onset COVID-19. | *32647672* 32647672 | ||
PMC7305637 250. Massive Pulmonary Thromboembolism in Patients with COVID-19; Report of Three Cases. | *32613200* 32613200 | ||
PMC7296606 251. Association of New Coronavirus Disease with Fragility Hip and Lower Limb Fractures in Elderly Patients. | *32607400* 32607400 | ||
PMC7296607 252. Molecular Aspects of Co-morbidities in COVID-19 Infection. | *32607393* 32607393 | ||
PMC7250780 253. La alteracion del olfato y el gusto en pacientes COVID-19. Un recurso diagnostico en atencion primaria. | *32620292* 32620292 | ||
PMC7352096 254. Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report. | *32652938* 32652938 | ||
PMC7294189 255. Loss of taste and smell. | *32541708* 32541708 | ||
PMC7294264 256. Cardiac arrest precipitated by succinylcholine in a patient with COVID-19. Comment on Br J Anaesth 2020; 125: e255-7. | *32624186* 32624186 | ||
PMC7321041 257. Mild and asymptomatic cases of COVID-19 are potential threat for faecal-oral transmission. | *32615073* 32615073 | ||
PMC7305863 258. COVID-19 et greffe de cellules souches hematopoietiques : recommandations et situation au Maroc. | *32624167* 32624167 | ||
PMC7308737 259. Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines). | *32623296* 32623296 | ||
PMC7322153 260. A case of COVID-19 in a patient with a univentricular heart post total cavopulmonary connection (Fontan) surgery. | *32613935* 32613935 | ||
PMC7316647 261. Novel Coronavirus-Induced Right Ventricular Failure and Point of Care Echocardiography: A Case Report. | *32450565* 32450565 | ||
PMC7171054 262. Reflections of the Angiotensin Receptor Blocker Recall by the FDA and Repercussions on Healthcare. | *32318933* 32318933 | ||
PMC7263269 263. Cardiovascular factors predicting poor outcome in COVID-19 patients. | *32640385* 32640385 | ||
PMC7325208 264. Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series. | *32647526* 32647526 | ||
PMC7337628 265. ACE inhibitors/ARB use and COVID-19. Time to change practice or keep gathering data? | *32621743* 32621743 | ||
PMC7337721 266. Commentary: Rapid Testing of Healthcare Employees for COVID-19: What Can We Learn from the Seattle Experience? | *32621738* 32621738 | ||
PMC7242011 267. Interrelationship Between Coronavirus Infection and Liver Disease. | *32489653* 32489653 | ||
PMC7326630 268. Fatal COVID-19 in a Patient with End-Stage Liver Disease Wait-Listed for Liver Transplantation: An Evidence-Based Review of COVID-19 Screening Modalities Prior to Transplant. | *32617159* 32617159 | ||
PMC7245295 269. Thromboprophylaxis for medical inpatients with coronavirus disease 2019. | *32454190* 32454190 | ||
PMC7326463 270. Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19. | *32619736* 32619736 | ||
PMC7264932 271. Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia. | *32502643* 32502643 | ||
PMC7346822 272. Viral shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2. | *32653662* 32653662 | ||
PMC7341030 273. Vertical transmission and materno-fetal outcomes in 13 patients with coronavirus disease 2019. | *32652239* 32652239 | ||
PMC7332451 274. Reduction in healthcare-associated respiratory viral infections during a COVID-19 outbreak. | *32622953* 32622953 | ||
PMC7331556 275. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort. | *32622952* 32622952 | ||
PMC7316067 276. COVID-19 and generalized Myasthenia Gravis exacerbation: A case report. | *32634699* 32634699 | ||
PMC7295516 277. Should we mind for late neurologic manifestations from novel coronavirus? | *32570020* 32570020 | ||
PMC7311351 278. COVID-19 associated encephalopathy: Is there a specific EEG pattern? | *32615526* 32615526 | ||
PMC7353835 279. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. | *32654082* 32654082 | ||
PMC7267473 280. SARS-CoV-2-Infektion vor ersten Symptomen. | *32514264* 32514264 | ||
PMC7267472 281. Diabetes: Ein Risikofaktor bei COVID-19. | *32514262* 32514262 | ||
PMC7351646 282. COVID-19-associated acute cerebral venous thrombosis: clinical, CT, MRI and EEG features. | *32653019* 32653019 | ||
PMC7255399 283. Implications of Obesity for the Management of Severe Coronavirus Disease 2019 Pneumonia. | *32452889* 32452889 | ||
PMC7314346 284. Clinical Features of Coronavirus Disease 2019 Patients With Mechanical Ventilation: A Nationwide Study in China. | *32618693* 32618693 | ||